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Summary 
 
In eukaryotes, mRNA turnover starts with the truncation of 3ʹ′ poly(A) tail and 
proceeds with either 3ʹ′-to-5ʹ′ degradation by the exosome complex or with decapping 
followed by 5ʹ′-to-3ʹ′ degradation by Xrn1. mRNA decapping is catalyzed by the 
decapping enzyme complex Dcp1-Dcp2 and is regulated by a highly conserved set of 
decapping activator proteins, including Pat1, Dhh1, Edc3 and the heptameric Lsm1-7 
complex. The mechanisms regarding the interplay of mRNA decapping activators 
remains elusive owing to limited structural and biochemical understanding. My 
doctoral research was focused on elucidating the structural and functional roles of 
mRNA decapping activators involved in mRNA decay. 
Pat1 has a modular domain architecture that allows it to interact with multiple 
decapping activators simultaneously. Pat1 acts as a bridging factor between the 3ʹ′-end 
and the 5ʹ′-end of the mRNA by interacting with multiple proteins involved in 
decapping. The interaction of S. cerevisiae Pat1 N-terminus with the DEAD-box 
protein Dhh1 was characterized by biochemical pull-down assays and binding 
affinities were determined quantitatively by isothermal titration calorimetery. Based 
on these experiments, the crystal structure of Dhh1 bound to Pat1 was determined at 
2.8 Å resolution. The structure reveals that Pat1 wraps around RecA2 domain of 
Dhh1 via evolutionary conserved interactions. This conserved surface of Dhh1 is also 
implicated in interaction with another decapping activator, Edc3, rationalizing why 
Pat1 and Edc3 binding to Dhh1 is mutually exclusive. These interactions were 
supported by testing mutations in in vitro assays with the yeast proteins and in co-
immunoprecipitation assays with the corresponding human orthologs.  Furthermore, 
structural analysis combined with RNA pull-down assays and a crosslinking mass 
spectrometry based approach gave definitive evidence that Dhh1 engages with Pat1, 
Edc3 and RNA in a mutually exclusive manner. 
The Lsm1-7 complex is another important activator of mRNA decapping. It protects 
the mRNA transcripts from 3ʹ′-end degradation and enhances the mRNA decapping. I 
determined the crystal structure of the Lsm1-7 complex at 2.3 Å resolution showing a 
hetero-heptameric complex of Lsm1-7 proteins that make a ring-like overall topology. 
Furthermore, an unusual helical structure of Lsm1 C-terminal extension and protrudes 
into the central channel of the heptameric ring, explaining how it is modulates the 
RNA binding properties of the complex.  
The Lsm1-7 complex interacts with the C-terminal domain of Pat1. Structure 
determination of this octameric Lsm1-7-Pat1 complex at 3.7 Å gave insights into the 
interaction of Pat1 with Lsm1-7 complex. Unexpectedly, Pat1 binds to Lsm2 and 
Lsm3 but not with the cytoplasmic specific subunit Lsm1. The Pat1 C-terminus 
makes a super-helical structure consisting of HEAT-like repeats of anti-parallel 
helices similar to the structure of its human ortholog. Structure based mutagenesis 
analysis by in vitro pull-downs showed that these interactions are conserved.  
This doctoral thesis gives structural and mechanistic insight into the role of multi-
domain protein Pat1 and how it engages at two distinct ends of mRNA by interacting 
with Dhh1 at 5ʹ′-end and with Lsm1-7 complex that at 3ʹ′-end. Combining these results 
present a model of dynamic interplay of these activators and gives a better 
understanding of protein-protein and protein-RNA interaction network in the 
decapping machinery. 
 
 
1 Preface 
 
This thesis is written in a cumulative style because my doctoral research work lead to 
two first author publications. Both the research papers are related and represent the 
work I did during the last three and a half years. The introduction chapter covers the 
broader field of research and its current status. Chapter three includes the full original 
manuscripts attached including detailed material and methods, results and discussion. 
Chapter four deals with the extended discussion of both the papers and puts forth the 
major advancement in the field contributed by this thesis. In the end, a brief outlook is 
presented. 
 
 
 
Sharif, H., Ozgur, S., Sharma, K., Basquin, C., Urlaub, H., and Conti, E. (2013). 
Structural analysis of the yeast Dhh1-Pat1 complex reveals how Dhh1 engages Pat1, 
Edc3 and RNA in mutually exclusive interactions. Nucleic Acids Res. 41, 8377–8390 
(2013). 
 
Sharif, H and Conti, E. Architecture of the Lsm1-7-Pat1 complex: A conserved 
assembly in eukaryotic mRNA turnover. Cell Reports. 5, 283–291 (2013). 
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3 
 
 
2 Introduction 
 
2.1 Mechanism of mRNA turnover 
 
The control of post-transcriptional gene expression in eukaryotes includes regulation 
of every step involved in messenger RNA (mRNA) metabolism (Moore, 2005). From 
transcription and splicing in the nucleus to the cytoplasmic export, translation and 
degradation of the mRNAs, all aspects are stringently controlled by several cellular 
and non-cellular factors (Garneau et al., 2007; Moore, 2005). 
Eukaryotic mRNAs actively involved in the translation pool in the cytoplasm can be 
distinguished from those which are destined for degradation by having a 5ʹ′-
methylguanosine (m7GpppN) cap structure and a polyadenlylated 3ʹ′ end (Cougot et 
al., 2004b; Garneau et al., 2007; Parker and Sheth, 2007). The m7G cap structure 
protects the translating mRNAs from degradation and is protected by the cap-binding 
proteins complex eIF4F, which consists of eukaryotic initiation factors eIF4E, eIF4A, 
eIF4G (Sonenberg and Hinnebusch, 2009). Moreover, the mRNA poly(A) tail is 
protected by poly(A)-binding proteins (Pab1) which shield the mRNA from 
exonucleases and interact with eIF4G (Jackson et al., 2010; Sonenberg and 
Hinnebusch, 2009). The cooperative binding of eIF4F component eIF4G with Pab1 is 
believed to circularize the mRNA restricting the mRNA decay factors and promoting 
the faithful translation of the mRNA message (Topisirovic et al., 2011; Wells et al., 
1998). 
Two major pathways of mRNA degradation (Figure 2.1) start with the shortening of 
polyadenylated (poly(A)) tail (Chen and Shyu, 2011). Deadenylation is mainly 
mediated by the Pan2-Pan3 and Ccr4-Not deadenylase complexes (Wahle and 
Winkler, 2013). Following deadenylation, mRNAs are targeted for 5ʹ′-to-3ʹ′ decay, 
which is initiated by removal of m7G cap from the target mRNAs, by a process called 
mRNA decapping and is followed by 5ʹ′ exonucleotic decay by Xrn1 (Decker and 
Parker, 1993; Dunckley and Parker, 1999; Hsu and Stevens, 1993). Moreover, 
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deadenylated mRNAs can be degraded by the exosome mediated 3ʹ′-to-5ʹ′ decay 
pathway (Franks and Lykke-Andersen, 2008; Januszyk and Lima, 2014; Mitchell et 
al., 1997) and the remaining cap structure is hydrolyzed by scavenger decapping 
enzyme DcpS (Liu et al., 2002) . The two-pathway conservation amongst all 
eukaryotes shows redundancy and can be attributed to tight control of mRNA 
degradation. 
 
 
 
 
Figure 2.1: General mechanism of eukaryotic mRNA decay  
 
Deadenylation dependent degradation is the major degradation mechanism in which 
mRNAs to be degraded are deadenylation of 3ʹ′-poly(A) tail of by Pan-Pan3 and Ccr4-
Not complex. Following deadenylation the mRNA substrates can follow 5ʹ′-to-3ʹ′ 
decapping dependent decay pathway. In this pathway, the decapping enzymes Dcp1-
Dcp2 hydrolyze the 5ʹ′-cap structure from the mRNAs with the help of decapping 
activator proteins. Following decapping, the exonuclease Xrn1 recognizes the 
decapped mRNAs and degrades them in 5ʹ′-to-3ʹ′ direction. Alternatively, mRNAs can 
follow 3ʹ′-to-5ʹ′ degradation pathway in which the exosome degrades the mRNAs from 
3ʹ′ end and the remaining cap structure is then removed by scavenger of decapping 
(DcpS). For simplification, the mRNA is shown as linear line (adapted from (Garneau 
et al., 2007)) 
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2.2 Deadenylation in eukaryotes: The first step to decay 
 
The shortening of 3ʹ′-poly(A) tail signals the mRNA degradation. Two deadenylase 
complexes conserved from yeast to mammals have been studied extensively; the 
Ccr4-Not and Pan2-Pan3 complexes (Reviewed in (Chen and Shyu, 2011)). The 
major deadenylase complex in all eukaryotes is the Ccr4-Not complex (Tucker et al., 
2001) that consists of two catalytic subunits Ccr4 and Caf1/Pop2 (Basquin et al., 
2012) and Not proteins (Not1, Not2, Not3, Not4, Not5) (Bhaskar et al., 2013; Wahle 
and Winkler, 2013). The second type of deadenylase complex conserved amongst all 
eukaryotes contains the catalytic subunit Pan2 (catalytic subunit) and the regulatory 
subunit Pan3 (Boeck et al., 1996; Brown et al., 1996; Zuo and Deutscher, 2001).  
Mature mRNA that is shuttled to the cytoplasm is bound by many accessory proteins 
for protection from exonuclueases and contain poly(A) tail bound by multiple copies 
of Pab1 (Mangus et al., 2004; Muhlrad et al., 1994). Deadenylation is a step-wise 
process in which the initial catalytic step is accomplished by the Pan2-Pan3 complex 
that starts shortening of the poly(A) tail (Brown and Sachs, 1998). The catalysis is 
eventually taken over by the Ccr4-Not complex which leaves an oligo(A) tail on 
mRNAs (Tucker et al., 2001; Yamashita et al., 2005; Zheng et al., 2008). Pab1 is 
currently believed to promote activity of Pan2 while restricts the activity Ccr4 (Boeck 
et al., 1996; Tucker et al., 2002), implying that for Ccr4 deadenylase activity Pab1 
must be displaced from mRNAs to facilitate the deadenylation of remaining poly(A) 
tail to an oligo(A) tail (Tucker et al., 2002; Tucker et al., 2001). Moreover, Pan2 has 
been shown to interact with Caf1/Pop2 of the Ccr4-Not complex by co-
immunoprecipitation studies (Zheng et al., 2008). These events lead to formation of 
an assembly of deadenylases that facilitate two-step deadenylation process in a 
coordinated manner (Zheng et al., 2008). 
Once the 3ʹ′-end of mRNAs contain oligo(A) tail, they are either targets of the mRNA 
decapping activator Pat1-Lsm1-7 complex assembly at 3ʹ′-end, which in turn promotes 
5ʹ′-to-3ʹ′ decay via decapping (He and Parker, 2001; Tharun and Parker, 2001). 
Deadenylated mRNAs can follow the 3ʹ′-to-5ʹ′ decay pathway mediated by the 3ʹ′ 
exonuclease complex, the exosome (Chlebowski et al., 2013).  
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2.3 Deadenylation dependent degradation pathways in 
eukaryotes 
 
2.3.1 The Exosome mediated 3ʹ′-to-5ʹ′ mRNA decay pathway 
 
The eukaryotic exosome is a multi-protein ribonuclease complex, which is essential 
for 3ʹ′-to-5ʹ′ mRNA degradation (Figure 2.1) and also for processing and degradation 
of many other kinds of RNAs (Allmang et al., 1999; Mitchell et al., 1997).  The core 
of exosome (termed as Exo-9) is conserved in eukaryotes and is formed by six RNase 
PH-like proteins forming a central channel and three other RNA-binding proteins 
containing S1 and KH domains (Rrp4, Rrp40, Csl4) (reviewed in (Januszyk and 
Lima, 2014)). The eukaryotic exosome (Exo-9) is catalytically inactive and needs a 
catalytic subunit for its activity. In cytoplasm, Rrp44 that binds to distal end of S1 and 
KH ring provides this activity and this catalytically active 3ʹ′ exonuclease complex is 
termed Exo-10. However, in nucleus the exosome exists as Exo-11 complex 
containing two exonucleases Rrp44 and Rrp6 (Liu et al., 2006; Makino et al., 2013).  
The eukaryotic exosome interacts with many co-factors. These co-factors modulate 
exosome activities by providing structural roles and also by interaction and processing 
of different RNA substrates. In cytoplasm, the exosome interacts with Ski protein 
complex (Ski2, Ski3, Ski8) via conserved Ski7 protein (Halbach et al., 2013; Halbach 
et al., 2012; Wang et al., 2005). Whereas in nucleus, exosome activity is modulated 
by its interaction with TRAMP complex containing Mtr4, Trf4 and Air2 proteins 
(Callahan and Butler, 2010; Weir et al., 2010). Following the 3ʹ′-to-5ʹ′ catalytic activity 
of the exosome, the short mRNAs with remaining cap structure are metabolized by 
the scavenger-decapping enzyme (DcpS) (Liu et al., 2002). 
 
2.3.2 The Xrn1 dependent 5ʹ′-to-3ʹ′ decay pathway 
 
The messenger ribonuleoprotein (mRNP) bound with decapping enzymes Dcp1-Dcp2 
and decapping activator proteins, is destined to follow decapping mediated 5ʹ′-to-3ʹ′ 
decay pathway. The decapping of mRNA by Dcp2 with its co-activator Dcp1 
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generates 5ʹ′-monophosphorylated mRNAs. These are the substrates of 5ʹ′ 
exonucleases Xrn1 that readily degrades the mRNA transcripts (Reviewed in (Coller 
and Parker, 2004)).  
Several factors play a crucial role for the decapping to occur. First the deadenylation 
of mRNA transcripts, secondly, the accessibility of the cap structure which includes 
the dissociation of the cytoplasmic cap-binding proteins and thirdly, the association of 
Dcp1-Dcp2 to the 5ʹ′ cap and assembly of mRNP including many activators of 
decapping Dhh1, Pat1, Edc3, Lsm1-7 complex (Chen and Shyu, 2011; Coller and 
Parker, 2004; Parker, 2012). Translationally repressed mRNAs associated with 
decapping proteins and with many other appear to assemble in distinctive cytoplasmic 
processing-bodies (P-bodies) (Decker and Parker, 2012) (Discussed in Section 2.3.1).  
 
2.3.2.1  The decapping enzymes Dcp1-2: the duo that decaps 
the mRNA  
 
In eukaryotes, mRNA is decapped by evolutionary conserved enzyme Dcp2 and its 
catalytic activity is dependent on its co-factor Dcp1 (Dunckley and Parker, 1999; 
Steiger et al., 2003; van Dijk et al., 2002; Wang et al., 2002). 
Dcp2 catalyzes hydrolysis of 5ʹ′ 7-methylguanosine (m7GpppN) cap from the mRNAs 
and releases m7GDP and 5ʹ′ mono-phosphorylated mRNA which is substrate of rapid 
decay by Xrn1 (Figure 2.1) (Cohen et al., 2005; She et al., 2008; Steiger et al., 2003). 
Dcp2 primarily decaps the methylated mRNAs with either m7G-capped or m2,2,7G-
capped mRNA and show poor catalytic activity towards the un-methylated G-capped 
mRNA transcripts (Cohen et al., 2005; Piccirillo et al., 2003; Steiger et al., 2003). 
Dcp2 belongs to Nudix family of pyrophosphatases and requires a divalent metal ion 
(Mg2+) for its catalytic activity (Steiger et al., 2003; van Dijk et al., 2002). Dcp2 and 
its orthologs contain an N-terminus regulatory α-helical domain followed by Nudix 
domain and C-terminal highly divergent domain (She et al., 2004; She et al., 2008; 
Steiger et al., 2003; van Dijk et al., 2002). In yeast Dcp2, N-terminus and Nudix 
domains are enough to promote decapping (Dunckley and Parker, 1999; Harigaya et 
al., 2010). 
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Crystal structures of Schizosaccharomyces pombe Dcp2 (Figure 2.2) in different 
conformations revealed that its N-terminus and Nudix domain are linked with a 
flexible segment, making a bilobed structure that can adopt an active (closed) and 
inactive (open) conformation depending on the presence of cap-analog and its 
interaction with Dcp1 (EVH domain) (She et al., 2008). Dcp1 contains an EVH 
domain at N-terminus that interacts with Dcp2 and modulates its functions by 
stabilizing the closed conformation (She et al., 2004; She et al., 2008).   
This interaction surface of Dcp1 is surprisingly not conserved and supports that in 
metazoans other activators or a mediator of this interaction may be needed to induce 
this active conformation. Indeed, additional factors, Edc4 and Hedls have been 
identified in higher eukaryotes (Chang et al., 2014; Fenger-Gron et al., 2005; Yu et 
al., 2005).   
 
 
 
 
Figure 2.2: Crystal structures of S. pombe Dcp1-Dcp2 
 
Dcp1 is depicted in green while Dcp2 N-terminal domain (NTD) and Nudix domain in 
blue, ATP analogue in black (PDB: 2qkm) (She et al., 2008).  
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2.3.2.2 Xrn1 is a highly conserved 5ʹ′ exoribonuclease 
 
Xrn1 is a 5ʹ′ processive exoribonuclease involved in decapping induced mRNA decay 
pathway and is highly conserved from yeast to mammals (Jones et al., 2012). 
Degradation of mRNA by Xrn1 depends on nature of 5ʹ′-end of mRNA (Pellegrini et 
al., 2008). Following decapping by Dcp1-Dcp2 enzyme complex, 5ʹ′ 
monophosphorylated mRNAs are the targets of 5ʹ′ exoribonucleotic decay by Xrn1 
(Coller and Parker, 2004; Stevens, 1980; Stevens and Poole, 1995). RNA hydrolysis 
by Xrn1 is predominant and specific to 5ʹ′ monophosphorylated substrates, whereas, 
Xrn1 shows poor hydrolysis of the substrates bearing 5ʹ′-cap structure, triphosphate or 
hydroxyl group (Stevens, 1980; Stevens and Poole, 1995).  
Xrn1 physically interacts with the decapping enzyme Dcp1, with decapping activators 
Pat1-Lsm1-7 complex and co-localize to P-bodies with these proteins (Braun et al., 
2012; Nissan et al., 2010; Parker and Sheth, 2007).  In vitro analysis revealed that the 
Pat1 C-terminus interacts with Xrn1 (Nissan et al., 2010). Moreover, Dcp1 interacts 
with C-terminus of Xrn1 which is also supported by structural analysis (Braun et al., 
2012) rationalizing the molecular basis of interaction between mRNA decapping and 
degradation (Braun et al., 2012). In addition, Xrn1 is also involved in mRNA 
degradation of endonucleotic products in mRNA surveillance pathways (Non-sense 
mediated decay and No-go decay) (Chen and Shyu, 2003; Orban and Izaurralde, 
2005).  
 
2.3.3 Processing (P) bodies: the foci for decapping and 5ʹ′-to-3ʹ′ 
degradation 
 
In eukaryotic cells, translationaly inert mRNAs tend to cluster in two discrete 
cytoplasmic foci known as Processing bodies (P-bodies) and stress granules 
(reviewed in (Decker and Parker, 2012; Franks and Lykke-Andersen, 2008)). P-
bodies are the cytoplasmic bodies known to contain all proteins involved in the 
mRNA decapping pathway. Studies in yeast and metazoans showed that P-bodies 
contain mRNA decapping proteins such as Dcp1/Dcp2, Dhh1, Pat1, Edc3, Lsm1-7, 
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exoribonuclease Xrn1 and also the deadenylase complex Ccr4-Not (Beckham et al., 
2008; Fenger-Gron et al., 2005; Ingelfinger et al., 2002; Sheth and Parker, 2003). In 
addition to these general decay factors, P-bodies contain components from non-sense 
mediated decay (NMD) pathway (Durand et al., 2007; Unterholzner and Izaurralde, 
2004). Additionally, in mammals they contain the miRNA repression machinery 
including GW182 (Eystathioy et al., 2003). This suggests the diverse roles of P-
bodies and involvement of proteins from various decay pathways (Ding et al., 2005; 
Eulalio et al., 2008; Sheth and Parker, 2006; Unterholzner and Izaurralde, 2004).  
Increase of mRNA localization into P-bodies has been shown in yeast upon 
translation repression, glucose deprivation or environmental stress (Teixeira et al., 
2005). The repressed mRNAs can shuttle back to polysomes if the stress conditions 
are relieved (Brengues et al., 2005; Cougot et al., 2004a; Eulalio et al., 2007b; 
Teixeira et al., 2005).  Formation of P-bodies is largely RNA dependent indicated by 
in vitro RNAse treatment of P-bodies and further biochemical and microscopic 
analysis (Teixeira et al., 2005). 
In comparison with P-bodies, stress granules contain not only the decay machinery 
but also the translation initiation factors eIF4A, eIF4G, eIF4E, Pab1, ribosomal 
subunits (40S) and some factors from the decay pathway Ge-1/Hedls (in Metazoans) 
and Dhh1/DDX6/Rck (Buchan et al., 2008; Eulalio et al., 2007b; Kedersha et al., 
2002; Liu et al., 2005b; Yu et al., 2005). They are extensively studied in mammalian 
cells and in yeast (Decker and Parker, 2012; Eulalio et al., 2007a). 
  
2.4  Decapping activators and their mechanism of promoting 
decapping 
 
The mRNA decapping is enhanced by many proteins known as mRNA decapping 
activators that are required for the faithful transition of actively translating mRNAs to 
the repressed and ready-for-decay state.  This group of proteins is highly conserved 
amongst eukaryotes (Coller and Parker, 2004; Franks and Lykke-Andersen, 2008). 
The major set of proteins conserved in all eukaryotes includes Dhh1, Pat1, Edc3 and 
Lsm1-7 and many other proteins specific to some eukaryotes. Summary of functions 
of these highly conserved decapping activators is described in Table1 (Parker, 2012). 
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 Activators of decapping affect or promote the decapping in different ways and at 
different steps of mRNA decapping. The factors, Dhh1 and Pat1, enhance decapping 
by promoting translation repression either by blocking the formation of pre-initiation 
48S complex or by physically interacting with either the mRNA destined for decay or 
other activator proteins (Carroll et al., 2011; Coller and Parker, 2005; Nissan et al., 
2010; Pilkington and Parker, 2008).  
Another set of proteins consists of the enhancer of decapping Edc3 and Pat1 that 
promotes decapping by interacting with Dcp1-Dcp2 and stimulates Dcp2 catalytic 
activity (Coller and Parker, 2005; Nissan et al., 2010; Tritschler et al., 2007). 
Furthermore, Edc3 helps in recruitment of decapping enzyme complex to mRNAs 
(Decker et al., 2007; Kshirsagar and Parker, 2004; Tritschler et al., 2007).  
Another conserved role of mRNA decapping activators is to rearrange the mRNP to 
enhance the decapping. The Pat1-Lsm1-7 complex not only interacts readily with the 
deadenylated mRNAs in vivo but also protects the dedadenylated 3ʹ′-end of mRNA 
from partial degradation by the exosome thus promoting the decapping pathway (He 
and Parker, 2001; Nissan et al., 2010; Tharun et al., 2000) 
Promoting larger assemblies of mRNPs, to gather all the activators and decapping 
enzymes, is another feature in which Pat1 and Edc3 prove to be crucial by providing a 
scaffold for the assembly of these mRNPs which further promote the decapping 
(Figure 2.3) (Decker et al., 2007; Nissan et al., 2010; Tritschler et al., 2007). 
 
 
Factors Function 
Dcp1/Dcp2 
mRNA decapping enzyme, Dcp2: catalytic subunit member of Nudix 
family, hydrolyzes m7GDP and 5ʹ′ p-RNA. Dcp1: stimulatory subunit, 
Evh1/WH1 family member, blocked by eIF4E bound to mRNA cap. 
Xrn1 
Major cytoplasmic 5ʹ′-to-3ʹ′ exonuclease, Processive and requires 5ʹ′ 
mono-phosphate 
Pat1 
Activates general mRNA decapping, serves as scaffolding protein for 
decapping complexes, represses translation initiation and stimulates 
Dcp2, interacts with Lsm1-7 complex and prefers to bind 3ʹ′ end of 
oligoadenylated mRNA, promotes P-body assembly, after 
deadenylation stabilizes 3ʹ′ ends against 3ʹ′ trimming. 
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Lsm1-7 
complex 
Required for efficient decapping, forms heptameric ring complex and 
binds to oligo or deadenylated mRNAs. 
Dhh1 
Required for efficient decapping of mRNAs, member of ATP 
dependent DEAD box RNA helicase family. 
Inhibits translation initiation in vitro upstream of 48S complex 
formation, accumulated in both stress granules and P-bodies, interacts 
with Dcp2, Pat1, Scd6, Edc3. 
Edc3 
RNA binding protein, binds and directly stimulates Dcp2, plays 
major role in aggregation of P-bodies and serves as a scaffold for 
decapping factors. 
Scd6 
RNA binding protein related to Edc3, genetic interaction with Edc3 
and synthetic decapping defect in ∆Edc3 and ∆Scd6, repress 
translation by binding eIF4G, interacts with Dhh1, Dcp2, Pat1. 
 
 
Table1: mRNA decapping factors  
 
General and highly conserved S. cerevisiae decapping activators with outlined 
functional details. Adapted from (Parker, 2012) 
 
2.4.1 Assembly of mRNA decapping complex 
 
Various studies including yeast two-hybrid screens and immunoprecipitation assays 
revealed mRNA decapping activators have a conserved extensive network of protein-
protein and protein-RNA interactions (Reviewed in (Parker, 2012) (Coller and Parker, 
2005; Nissan et al., 2010). 
Two distinct complexes can be identified. First, a complex consisting of Pat1, Lsm1-7 
and Xrn1 has been identified by tandem-affinity purifications (TAP) and co-
immunoprecipitation that binds to 3ʹ′-end of deadenylated mRNAs (Bouveret et al., 
2000; Nissan et al., 2010). Another complex containing the core-decapping enzymes 
Dcp1-Dcp2 together with Edc3, Dhh1, Scd6 assemble at the 5ʹ′-end of mRNAs. Edc3 
provides the structural scaffold for the assembly of this sub-complex and enhances the 
Dcp1-Dcp2 activity (Fromm et al., 2012).  
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These two discrete complexes have been shown to interact via Pat1, the large scaffold 
protein that keeps both ends of the mRNA in a close proximity (Figure 2.3) (Nissan et 
al., 2010). Pat1 plays the central role of providing the scaffold for assembly of the 
whole decapping complex by interacting with Dhh1, Edc3, Dcp2, Lsm1-7 (Nissan et 
al., 2010).  
 
 
 
 
 
 
 
Figure 2.3: Model of S.cerevisiae mRNA decapping complex with circularized 
mRNA 
 
 Interactions shown are derived from in vivo and in vitro data (Braun et al., 2010; 
Coller and Parker, 2005; Haas et al., 2010; He and Parker, 2001; Nissan et al., 
2010; Ozgur et al.; Pilkington and Parker, 2008; She et al., 2004; Tharun et al., 
2000). Proteins are color coded as represented in Section 3.1 and Section 3.2.   
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2.4.2 General mRNA decapping activators 
 
2.4.2.1 Pat1: a modular protein with diverse functions 
 
Pat1 (protein associated with topoisomerase II) an 88-kDa protein was first identified 
as a protein associated with topoisomerase II (Wang et al., 1996). Yeast two-hybrid 
analysis and immuno-fluorescence based cellular localization experiments showed 
that Pat1 has the ability to localize into nucleus (Jensen et al., 2000; Marnef et al., 
2012). However, most of the work in the past decade has been focused on its 
cytoplasmic functions, which are diverse and well studied with reference to mRNA 
decay. 
Pat1 has multiple domains (Nissan et al., 2010) that are conserved amongst its 
othologs in human Pat1b (Ozgur et al., 2010) and in Drosophila HPat (Haas et al., 
2010). In humans there are two Pat1 homologs termed Pat1a and Pat1b. By 
combining in vitro localization experiments with the YFP-tagged protein and 
immuno-fluorescence microscopy of endogenous Pat1 homologs it was observed that 
only Pat1b is localized to the P-bodies revealing its role in mRNA decay (Haas et al., 
2010; Ozgur et al., 2010). Although the domain boundaries differ in different species 
but the functions of these domains are highly interrelated.  
Pat1 serves as a scaffold for the mRNA decapping machinery and translation 
repression (Figure 2.3) (Coller and Parker, 2005; Nissan et al., 2010). Pat1 seems to 
be at the intersection of translational repression, mRNA decapping and exonuclease 
decay by Xrn1. In vitro Pat1 directly interacts with the decapping protein Dcp1-Dcp2 
and stimulates the decapping activity (Nissan et al., 2010). Moreover, in vitro 
translation experiments show translation repression and inhibition of 48S complex 
formation upon addition of Pat1 in yeast (or its domains) (Nissan et al., 2010). In vivo 
over expression of Pat1 leads to accumulation of P-bodies and translation repression 
(Coller and Parker, 2005; Pilkington and Parker, 2008). Pat1 also interacts in an 
RNA-dependent manner with eIF4E, eIF4G and Pab1 thus validating its association 
with mRNA even before the deadenylation in the actively translating mRNAs 
(Bonnerot et al., 2000; Tharun and Parker, 2001). Furthermore, co-
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immunoprecipitation assays of human and Drosophila Pat1 reveals its interaction 
with the components of Ccr4-Not complex and Xrn1 (Haas et al., 2010; Ozgur et al., 
2010). These lines of information clearly explain Pat1 involvement in three very 
important and distinct steps for gene regulation.  
Fold prediction and sequence alignment of Pat1 suggests that Pat1 N-terminal 
domain, Proline (P)-rich region and middle domain are not structured or they might 
make secondary structure upon binding to other proteins (Braun et al., 2010). The 
only structured domain of Pat1 is its C-terminal domain whose crystal structure from 
its human ortholog Pat1b has been solved (Figure 2.4) (Braun et al., 2010). The 
structure shows a α-α super-helical structure of Pat1 composed of 13-helices related 
to HEAT-repeats or ARM-repeat superfamily (Braun et al., 2010). These helices 
make a basic solvent exposed surface, which is involved in RNA and Dcp2, Edc4 and 
Lsm1-7 interactions (Braun et al., 2010). 
 
 
 
Figure 2.4: Crystal structure of human Pat C-terminal domain 
 
Depicted in blue ribbon representation with 13 alpha helices labeled. (PDB: 2xer) 
(Braun et al., 2010).  
 
Pat1 has been shown to co-immunoprecipitate with various yeast mRNAs (Tharun 
and Parker, 2001) and its middle and C-terminal domain binds to poly(U) RNA, both 
in human and yeast (Haas et al., 2010; Pilkington and Parker, 2008). This suggests 
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that Pat1 either directly interacts with RNA or indirectly by its RNA-interacting 
partners. Indeed, in vitro analysis of human Pat1 C-terminus shows its interaction 
with RNA in size-exclusion chromatography experiments (Braun et al., 2010).  
 
2.4.2.2 Dhh1 is a DEAD box protein 
 
 
The DEAD-box proteins belong to super-family 2 (SF2) of RNA helicases that are 
involved in different cellular processes (Fairman-Williams et al., 2010). They not 
only possess unwinding RNA properties by utilizing ATP but also ATP-dependent 
clamping of RNA to regulate its function and to form RNA-protein complexes 
(RNPs) (Linder and Jankowsky, 2011). These proteins are characterized by having 
nine distinct motifs that are involved in RNA binding, ATP-binding and its hydrolysis 
(Linder and Jankowsky, 2011). 
Yeast Dhh1 and its orthoglos in Schizosaccharomyces pombe (Ste1), Xenopus laevis 
(Xp54), Drosophila melanogaster (Me31B), Caenorhabditis elegans (CGH-1) and in 
mammals (DDX6/Rck) share a high sequence similarity in two RecA-like domains 
while C and N-terminal are not well conserved. The wealth of biochemical and 
structural data provided a glimpse of its involvement in wide variety of cellular 
processes (Presnyak and Coller, 2013). Sequence analysis reveals an N-terminus 
extension present in DDX6/Rck in human. Dhh1 is interesting in having Asn (N)-rich 
segment in N-terminus and Gln (Q)-rich region at C-terminus that might be involved 
in aggregation of the proteins leading to P-body formation (Cheng et al., 2005).  
Dhh1 and its orthologs are versatile proteins and are shown to be involved in the 
interaction with mRNA decapping machinery, with deadenylation complexes and in 
promoting translation repression and P-body localization (Coller and Parker, 2005; 
Coller et al., 2001; Maillet and Collart, 2002; Teixeira et al., 2005)  
The crystal structure of Dhh1 (Cheng et al., 2005) showed the protein with two RecA-
like domains in an open conformation (Figure 2.5). Structural analysis showed a 
unique rearrangement of RecA domains because of the inter-domain interactions that 
might restrict or regulate its activities (Cheng et al., 2005). Indeed, these interactions 
play a crucial role in regulating the ATPase activity of the molecule (Dutta et al., 
2011).  Mutations leading to the disruption of these inter domain interactions 
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increased the overall ATPase activity and mRNA turnover, RNA binding and P-body 
accumulation in vivo (Dutta et al., 2011).  
 
 
 
 
 
 
Figure 2.5: Crystal structure of S. cerevisiae Dhh1 
 
The core helicase domains (RecA1 and RecA2) as depicted in two orientation in blue 
(PDB: 1s2m) (Cheng et al., 2005). 
 
RNA fluorescence polarization experiments revealed Dhh1 binds most strongly to 
poly(U) 10-12 mer RNA (Dutta et al., 2011). Its affinity remained similar with upto 
U20-mer RNA but decreased many folds if the RNA was smaller than 10 nucleotides 
(Dutta et al., 2011). Although most of the DEAD-box proteins were shown to be 
RNA-dependent ATPases in vitro but most of them did not show any RNA-depedent 
helicase activity (Linder and Jankowsky, 2011). Consistent with this, Dhh1 helicase 
activity has not been shown except for its Xenopus ortholog Xp54 which can unwind 
46 base pair duplex with 5ʹ′ overhangs ((Ladomery et al., 1997), reviewed in 
(Presnyak and Coller, 2013)).  
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2.4.2.3 Edc3: A scaffold for mRNA decapping enzymes 
 
Enhancer of decapping 3 (Edc3) belongs to the Lsm family of proteins. It plays an 
important role in P-body formation and is one of the activators of decapping, which 
was first identified in Saccharomyces cerevisiae (Kshirsagar and Parker, 2004; 
Tritschler et al., 2007). Protein family Lsm16 contains three different functional 
domains: an N-terminal Lsm domain, FDF domain (containing a consensus Phe-Asp-
Phe motif) and a C-terminal YjeF-N domain (Albrecht and Lengauer, 2004; 
Anantharaman and Aravind, 2004). These domains are evolutionary conserved and 
are involved in important cellular functions.  
Several in vivo and in vitro studies including genome wide analysis, proteome 
analysis and yeast-two hybrid showed that Edc3 interacts with mRNA decay proteins 
(Fromont-Racine et al., 2000; Gavin et al., 2002; Ito et al., 2001; Uetz et al., 2000). In 
yeast, the deletion of Edc3 results in reduced P-body numbers and defective mRNA 
decay as compared to wild-type cells (Decker et al., 2007; Kshirsagar and Parker, 
2004). Additionally, GFP-tagged Edc3 localizes to P-bodies showing that it is part of 
protein complexes involved in P-body assembly and stimulates the decapping activity 
of Dcp2 (Kshirsagar and Parker, 2004).  
Individual domains of Edc3 are involved in important interactions.  In yeast-two 
hybrid experiments complimented with in vitro pull-down assays Lsm domain of 
Edc3 interacts with catalytic domain of Dcp2 (Decker et al., 2007). While the co-
imunoprecipitation of Drosophila Lsm domain shows interaction with Dcp1 only and 
none of the other decapping factors (Tritschler et al., 2007). Its interaction with Dcp1 
or with DDX6/Me31B/Dhh1 is not sensitive to RNAse treatment showing that the 
interactions are RNA independent (Tritschler et al., 2007). In both orthologs, the N-
terminal Lsm domains showed that it is important for Edc3 localization in P-bodies 
(Decker et al., 2007; Eulalio et al., 2007c; Tritschler et al., 2007). The crystal 
structure of Lsm domain of human Edc3 (Figure 6A) and solution structure of 
Drosophila Edc3 reveal that Edc3 Lsm domain has a divergent Sm-fold, which lacks 
the canonical N-terminal helix in the overall fold (Figure 2.6). On this basis it can also 
be classified in the Tudor domain family (Tritschler et al., 2007). This Lsm domain 
shows not only the differences at the structural level but also it lacks RNA binding 
properties (Tritschler et al., 2007). 
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Similarly, pull-down experiments of recombinant FDF domain of yeast Edc3 show 
interaction with RecA2 domain of Dhh1. These results are further supported by the 
crystal structure of human Edc3 FDF peptide bound to RecA2 domain of DDX6/Rck 
(Figure 2.6) (Tritschler et al., 2009).  The structure shows a tight complex in which 
Edc3-FDF peptide adopts a helical conformation upon binding to DDX6. The 
structural analysis combined with mutational and competition studies shows that 
Dhh1/DDX6/Me31B has mutually exclusive interaction with Edc3, Pat1 and 
Tral/Scd6 that also has similar domain architecture (Tritschler et al., 2009; Tritschler 
et al., 2008).  
The YjeF-N domain of yeast Edc3 interacts with itself thus helps in dimerization of 
Edc3 (Fromont-Racine et al., 2000; Marino-Ramirez and Hu, 2002). Furthermore, 
human Edc3 also forms a dimmer (Figure 2.6) and its Yjef-N domain is responsible 
for the dimerization as tested by gel filtration and ultra-centrifugation experiments 
(Ling et al., 2008). Overall crystal structure of human Edc3 YjeF-N domain revealed 
that it adopts a Rossmann-like topology (Figure 6B) (Ling et al., 2008). Dimerization 
of Edc3 is important for its ability to bind RNA as well as for P-body assembly which 
supports that YjeF-N domain is likely to be essential domain providing not only 
structural properties but also functional properties to dimeric Edc3 protein in mRNA 
degradation (Decker et al., 2007; Ling et al., 2008). 
In the view of Edc3 functions, its direct interaction with decapping enzyme Dcp2 and 
modulation of its activity (Fromm et al., 2012) and in P-body formation (Eulalio et 
al., 2007a), it can be suggested that Edc3 provides the important scaffold for 
decapping enzyme complex Dcp1-Dcp2 to decap the mRNA transcripts and make 
them available for degradation by Xrn1. 
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Figure 2.6: Crystal structures of human Edc3 domains 
 
(Left): Crystal structure of human Lsm domain of Edc3 (PDB: 2vc8) (Tritschler et al., 
2007). (Middle): Crystal structure of human YjeF-N domain of Edc3. Two molecules 
of dimer are shown in different colors for clarity (PDB: 3d3j) (Ling et al., 2008) .  
(Right): RecA2 domain of DDX6 is shown in gray and Edc3 peptide containing FDF 
motif in salmon color (PDB: 2wax) (Tritschler et al., 2009). 
 
2.4.2.4 The Lsm1-7 complex: Ring that matters for protection 
of the 3ʹ′-end of mRNAs 
 
Sm and Sm-like (Lsm) proteins are an important part of mRNPs involved in mRNA 
degradation and pre-mRNA splicing (Beggs, 2005; He and Parker, 2000). Several 
structural and biochemical studies provide evidence that Sm proteins assemble into 
heptameric complexes involved in pre-mRNA splicing through the interactions with 
different snRNA (U1, U2, U4, U5) and play important role in the biogenesis of 
associated snRNAs (Bouveret et al., 2000; Leung et al., 2011; Pomeranz Krummel et 
al., 2009; Weber et al., 2010). A similar hetero-heptameric complex, containing Sm-
like (Lsm) proteins, is associated with U6 snRNA and in vitro analysis suggests that it 
binds to 3ʹ′ U-tract of U6 snRNA (Achsel et al., 1999; Kambach et al., 1999; Mayes et 
al., 1999; Salgado-Garrido et al., 1999; Zaric et al., 2005). In humans and yeast, 
Lsm2-8 protein complex co-immunoprecipitates with free U6 snRNA (Achsel et al., 
1999; Salgado-Garrido et al., 1999). Sm proteins require RNA for their heptameric 
assembly where as Lsm proteins readily assemble into ring link complexes in the 
absence of RNA substrate (Achsel et al., 1999; Salgado-Garrido et al., 1999). 
Several line of evidence on the yeast Lsm1-7 complex are provided by tandem-
affinity purification (TAP), deletion mutants and in humans by co-expression of wild-
type and mutant Lsm protein combined with fluorescence resonance energy transfer 
(FRET) analysis of Lsm1-7 complex revealed that it is vital for mRNA degradation 
(Bouveret et al., 2000; Ingelfinger et al., 2002; Tharun et al., 2000). First, it binds to 
Pat1 proteins and other decapping factors (Bouveret et al., 2000; Ingelfinger et al., 
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2002; Tharun et al., 2000; Tharun and Parker, 2001). Second, Lsm1 does not co-
immunoprecipitate with U6 snRNA (Mayes et al., 1999; Tharun et al., 2000). Third, 
the Lsm1-7 complex interacts with deadenylated mRNAs (Tharun and Parker, 2001). 
These evidences can be translated into that Lsm proteins exist in two distinct 
complexes, nuclear Lsm2-8 complex associated with U6 snRNA (Achsel et al., 1999; 
Mayes et al., 1999; Salgado-Garrido et al., 1999) while a cytoplasmic Lsm1-7 
complex associated with Pat1 protein and implicated in mRNA degradation (Bouveret 
et al., 2000; Ingelfinger et al., 2002; Tharun et al., 2000).  
Sm and Lsm proteins contain a common domain called the Sm-domain, which is 
followed by C-terminal extensions in some of the Sm proteins (Hermann et al., 1995; 
Seraphin, 1995). Crystal structures of Sm proteins revealed the conservation of the 
Sm domain that has an N-terminal α-helix followed by an anti-parallel 5-stranded 
(Figure) β-sheet (Kambach et al., 1999). Sm proteins are known to make hetero-
oligomeric assemblies in which β4 strand of one protein interacts with β5 strand of 
another (Kambach et al., 1999). The loop between β4, β5 and between β2, β4 
known as Sm1 and Sm2 motifs are highly conserved involved in protein-RNA 
interactions (Hermann et al., 1995; Kambach et al., 1999; Seraphin, 1995).  
 
 
 
 
Figure 2.7: Crystal structures of Lsm proteins 
 
(Left): Crystal structures of S. cerevisiae Lsm3 showing the conserved Sm fold having 
N-terminal α-helix followed by 5-stranded β-sheet (PDB: 3bw1) (Naidoo et al., 
2008). (Right): Crystal structure of S. pombe Lsm6/5/7 depicted in cyan, green and 
yellow respectively (PDB: 3swn) (Mund et al., 2011). 
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2.4.3 Functional roles of mRNA decapping activators 
 
2.4.3.1 P-body assembly and factors involved in it 
 
Assembly of P-bodies is proposed to be a stepwise process of first accumulation of 
different proteins at 3ʹ′ and 5ʹ′-end of mRNA and then accumulation of these sub 
complexes into larger microscopic foci (Reviewed in (Decker and Parker, 2012; 
Franks and Lykke-Andersen, 2008)). In yeast at least two proteins have been 
identified as key factors in the assembly of these structures i.e. Edc3 and Lsm4 
(Decker et al., 2007; Mazzoni et al., 2007; Reijns et al., 2008). YjeF-N domain of 
Edc3 and the Gln/Asn (Q/N) rich region (Prion-like) in Lsm4 C-terminus plays a 
central role in assembly of P-bodies (Decker et al., 2007; Mazzoni et al., 2007; Reijns 
et al., 2008). Participation of Edc3 in P-body formation appears to be conserved 
amongst higher organisms because the YjeF-N domain is evolutionary conserved 
(Ling et al., 2008). Moreover, the deletion of this domain does not greatly effect P-
body formation in Drosophila S2 cells or in yeast (Decker et al., 2007; Eulalio et al., 
2007b; Kshirsagar and Parker, 2004). Double deletion mutants of Edc3 and Lsm4 C-
terminal domain show a dramatic decrease in P-body formation upon glucose 
deprivation (Decker et al., 2007; Mazzoni et al., 2007; Reijns et al., 2008). In contrast, 
the Lsm4 C-terminal Q/N region in not conserved in metazoans. Many other proteins 
containing Q/N region have been identified in metazoan P-bodies e.g. GW182 protein 
involved in miRNA mediated repression and Hedls/Ge-1 protein that is part of 
decapping complex in metazoans (Eulalio et al., 2007b; Liu et al., 2005a; Yu et al., 
2005). Furthermore, the Q/N region of Lsm4 in metazoans is replaced by another 
Arg-Gly-Gly (RGG) domain, which plays a part in stress granule assembly (Tourriere 
et al., 2003). 
Although yeast and metazoans P-body formation appears to be different in some 
aspects, the overall mechanism is conserved. Many other proteins also contain Q/N 
(Prion-like) regions including Dhh1, Pop2, Not1, Ccr4, Not4 that not only regulate 
decapping, but also are active components of deadenlyation machinery (Chen and 
Shyu, 2011). Interactions amongst the prion-like degradation prone domains can also 
play important role in assembly of these granules (Decker et al., 2007) 
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2.4.3.2 Translation repression and decapping activation 
mediated by Dhh1 and Pat1 require their interplay  
 
 
Pat1 and Dhh1 are involved in mRNA degradation as well as in mRNA translation 
repression. Thus, these two decapping activators participate in two main events of 
post-transcriptional regulation (reviewed in (Marnef and Standart, 2010).  
Pat1 interacts with multiple partners of the decapping. Out of them, one prominent is 
its interaction with Dhh1 that is RNA independent (Coller et al., 2001; Fischer and 
Weis, 2002). Co-immunoprecipitation assays of human and Drosophila orthologs of 
Pat1 showed that its conserved N-terminal domain has inherent capability to bind to 
Dhh1 while the rest of the Pat1 domains failed to interact (Haas et al., 2010; Ozgur et 
al., 2010).  
Several studies show that Pat1 and Dhh1 have a critical role in controlling P-body 
formation and translation repression. While deletion of either Pat1 or Dhh1 in yeast 
repress the translation and induce P-body formation to some extent (Coller et al., 
2001; Fischer and Weis, 2002), deletion mutants of both Pat1 and Dhh1 show an 
additive accumulation of deadenylated mRNAs and translation repression (Coller and 
Parker, 2005). Clustering of translationaly repressed mRNA in P-bodies, growth 
defects and decrease in polysomes depend on both Pat1 and Dhh1 because deletion of 
either of them does not effect P-body formation to the same extent as double deletion 
of these proteins does (Coller and Parker, 2005; Sheth and Parker, 2003). In human 
cells, studies of interaction deficient mutants of Dhh1 and Pat1 with knockdown and 
rescue strategies concluded that Dhh1 require Pat1 binding to promote P-body 
assembly (Ozgur and Stoecklin, 2013). Likewise, Pat1 upon losing interaction with 
Dhh1 suppresses expression of mRNAs (Ozgur and Stoecklin, 2013).  These 
evidences show the importance of the Pat1 and Dhh1 complex that appears to have 
drastic effects on cell viability. 
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Figure 2.8: Domain architecture of S. cerevisiae decapping activators 
 
Solid arrow lines represent the interaction of DDX6-RecA2 bound to Edc3-FDF 
fragment (Tritschler et al., 2009). Dashed arrow lines represent the interactions dealt 
mainly in this thesis. Colors are used as according to (Figure 2.1, Section 3.1, Section 
3.2). 
 
2.4.3.3 Pat1-Lsm1-7 complex: as part of mRNA destined for 
degradation 
 
The interaction of Lsm1-7 complex with Pat1 is conserved in all eukaryotes and this 
complex promotes mRNA degradation by enhancing decapping (Reviewed in 
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(Tharun, 2009)). Pat1 is localized to P-bodies together with the Lsm1-7 complex. 
Furthermore, characterization of Pat1 domains showed that its middle and C-terminal 
domains are responsible for Lsm1-7 interaction (Braun et al., 2010; Haas et al., 2010; 
Nissan et al., 2010; Ozgur et al., 2010; Pilkington and Parker, 2008). The interaction 
of Lsm1-7 with the decapping machinery component i.e. Pat1, but not with the 
translation machinery indicates that this complex binds to mRNAs that are destined 
degradation (Tharun et al., 2000; Tharun and Parker, 2001). Furthermore, Pat1-Lsm1-
7 can be co-immunoprecipitated more efficiently with oligoadenylated transcripts 
than with polyadenylated ones and mutations in any of the components stabilize the 
mRNA bearing cap structure (Chowdhury et al., 2007; Tharun and Parker, 2001). In 
vitro analysis of purified Pat1-Lsm1-7 complex from yeast showed preference in 
binding to oligoadenylated RNAs (Chowdhury et al., 2007). Moreover, in vivo 
analysis of unadenylated mRNAs generated by ribozyme cleavage at 3ʹ′-end shows no 
binding to Pat1-Lsm1-7 but rather quick degradation by exosome-mediated decay (He 
and Parker, 2001; Meaux and Van Hoof, 2006). Combining all these results reveal 
Pat1-Lsm1-7 complex acts as a decapping activator complex by protecting 3ʹ′-end of 
deadenylated mRNAs from the exosome and thus promote decapping pathway (He 
and Parker, 2001).  
Interaction of Pat1-Lsm1-7 with oligo(A) tailed mRNAs is mediated by the presence 
of short poly(U) stretch at or near the 3ʹ′-end to which the Lsm1-7 complex binds 
(Chowdhury and Tharun, 2008). Multiple data suggest that a U-tract near the 3ʹ′-end 
facilitates binding of the Lsm1-7-Pat1 complex. First, Lsm proteins are shown to 
prefer binding to 3ʹ′ U-stretch in cell extracts (Song and Kiledjian, 2007) which is 
further supported by structural analysis of the U4 snRNP crystal structure bound to 
U4 snRNA at 3ʹ′ U-stretch (Leung et al., 2011). Second, the histone mRNAs which 
lack a poly(A) tail are oligouridylated first and then targeted for decapping via 5ʹ′-to-3ʹ′ 
decay pathway (Wilusz and Wilusz, 2008). 
 
2.5 Scope of this Work 
 
The importance of mRNA decapping activators has been demonstrated in literature 
and briefly described in the previous sections that how these factors involved in 
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faithful degradation of the mRNA. However, the mechanistic understanding of their 
assembly and the network of interactions amongst these activators remain elusive 
owing to limited structural details.   
The work in this thesis aims at the overall understanding of how does decapping 
activator Pat1 plays a crucial role of providing a scaffold for the decapping 
machinery? How does Pat1 keep both ends of the mRNA in a close proximity by 
interacting with Dhh1 at the 5ʹ′-end and with the Lsm1-7 complex at the 3ʹ′-end of the 
mRNA? Furthermore, how does Dhh1 engage with multiple partners in a mutually 
exclusive manner? Structural and biochemical approaches were employed to elaborate 
on these imperative questions in the field. 
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3 Results 
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ABSTRACT
Translational repression and deadenylation of eu-
karyotic mRNAs result either in the sequestration of
the transcripts in a nontranslatable pool or in their
degradation. Removal of the 50 cap structure is a
crucial step that commits deadenylated mRNAs to
50-to-30 degradation. Pat1, Edc3 and the DEAD-box
protein Dhh1 are evolutionary conserved factors
known to participate in both translational repression
and decapping, but their interplay is currently
unclear. We report the 2.8 Å resolution structure of
yeast Dhh1 bound to the N-terminal domain of Pat1.
The structure shows how Pat1 wraps around the C-
terminal RecA domain of Dhh1, docking onto the
Phe-Asp-Phe (FDF) binding site. The FDF-binding
site of Dhh1 also recognizes Edc3, revealing why
the binding of Pat1 and Edc3 on Dhh1 are mutually
exclusive events. Using co-immunoprecipitation
assays and structure-based mutants, we demon-
strate that the mode of Dhh1-Pat1 recognition is
conserved in humans. Pat1 and Edc3 also interfere
and compete with the RNA-binding properties of
Dhh1. Mapping the RNA-binding sites on Dhh1 with
a crosslinking–mass spectrometry approach shows
a large RNA-binding surface around the C-terminal
RecA domain, including the FDF-binding pocket. The
results suggest a model for how Dhh1-containing
messenger ribonucleoprotein particles might be re-
modeled upon Pat1 and Edc3 binding.
INTRODUCTION
The fate of eukaryotic mRNAs is linked to the complement
of proteins with which they associate to form messenger
ribonucleoprotein particles (mRNPs) (1). The 50 cap
structure and the 30 poly(A) tail are general hallmarks of
mRNPs that are targeted, either directly or indirectly, by
translation factors as well as mRNA decay factors.
Translation and decay are mutually dependent and antagon-
istic processes. The presence of the m7G cap structure at the
50 end, for example, is crucial for eIF4E binding and for
translation initiation [reviewed in (2)]. Conversely, its
removal by the decapping complex is a prerequisite for
50–30 degradation by the exoribonuclease Xrn1 [reviewed in
(3)]. Shortening of the poly(A)-tail is also linked to the shift of
mRNA from active translation to a translationally repressed
state in which the transcript can either be temporarily stored
or can be decapped and degraded [reviewed in (4)].
Although the exact sequence of events and interplay of
the factors involved in translational repression,
deadenylation and decay is currently debated, it is clear
that removal of the cap structure is an irreversible step
that commits the mRNA to 50–30 degradation [reviewed
in (3)]. Studies originally in yeast have shown that
decapping is catalyzed by Dcp1-Dcp2 (5,6) and is
activated in vivo by a cohort of regulators, including
Pat1, Edc3, Scd6, Dhh1 and the heptameric Lsm 1–7
complex (7–12). These core components of the decapping
machinery are conserved from yeast to humans, suggest-
ing the presence of common basic mechanisms (13).
Additional components as well as detailed intermolecular
interactions can, however, vary across species. All compo-
nents of the decapping/50–30 decay pathway co-localize in
P-bodies together with factors involved in translational
repression [reviewed in (14–17)]. Two P-body components
in particular, Dhh1 and Pat1 (18–24), appear to be at the
intersection of translational repression and mRNA
turnover [reviewed in (25,26)].
Pat1 is a conserved multidomain protein that forms a
scaffold for protein–protein interactions: the N-terminal
domain (NTD) binds Dhh1, the downstream region is
important for P-body formation and the middle and
C-terminal domains recruit a plethora of factors, including
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the decapping complex Dcp1–Dcp2, the Ccr4–Not complex,
the Lsm1–7 complex and Xrn1 (22–24,27). The Ccr4–Not
complex is amajor deadenylase: it trims themRNA30 end to
a short oligoadenylated tail that forms the platform for the
Lsm1–7 complex [reviewed in (28)]. Mechanistically, Pat1 is
thus believed to link the deadenylated 30 end with the
decapping factors at the 50 end. Indeed, Pat1 triggers
deadenylation when tethered to mRNAs in human and
Drosophila cells (22,24) and leads to a strong effect in
decapping upon deletion in yeast (8,9). In addition to its
prevalent role in mRNA degradation, in yeast Pat1 acts as
a translational repressor together with Dhh1 (18).
Dhh1 (also known as RCK/p54/DDX6 in humans,
Me31b in Drosophila melanogaster and CGH-1 in Caenor-
habditis elegans) has been known as a decapping activator
since the finding 10 years ago that its deletion in
Saccharomyces cerevisiae stabilizes mRNA transcripts and
inhibits decapping in vivo (10,11). However, Dhh1 does not
appear to function like Pat1 and Edc3/Sdc6 by directly
binding and activating the Dcp1–Dcp2 decapping
complex (27,29). Evidence is instead accumulating
pointing to a prevalent role of Dhh1 in translational repres-
sion in yeast (18,30) as well as in higher eukaryotes (21,31–
35). Dhh1 is highly abundant in all species examined to date
[yeast (36), Trypanosoma (37), Xenopus oocytes (38) and
mammalian cells (39)] and is present in large excess over the
expected mRNA substrates (39,40–42). Dhh1 belongs to the
DEAD-box protein family of RNA-dependent ATPases,
but has several unusual features. While other DEAD-box
proteins bind RNA and ATP in a cooperative manner (43),
Dhh1 binds RNA even in the absence of ATP (39,44). In
addition, the two RecA-like domains of Dhh1 are not
flexible as in most other DEAD-box proteins, but are
engaged in intramolecular interactions (45). This conform-
ational rigidity restricts the ATPase activity of Dhh1 in vitro
(44,45). In vivo, the ATPase activity of yeast Dhh1 is none-
theless critical for the dissociation from P-bodies (44,46).
Dhh1 and Pat1 are emerging as crucial players in guiding
the mRNPs from a translationally repressed state to a
decapping state. The C-terminal RecA-like domain
(RecA2) of Dhh1 is sufficient for translational repression
and accumulation in P-bodies in human cells (21). Studies
with the Drosophila orthologues have shown that this
domain of Dhh1 binds in a mutually exclusive manner
Edc3 and Scd6 (known as TraI in flies) (47), two partially
redundant proteins with a similar domain organization
(12). The C-terminal RecA-like domain is also required
to bind Pat1 (22). In this work, we have elucidated the
evolutionary conserved molecular mechanisms of the inter-
action between Dhh1 and Pat1, showing how Pat1 and
Edc3 compete for the same surface of Dhh1 and how
they impact on RNA binding. These results suggest that
Dhh1 might switch protein and RNA-binding partners in
the transition from translational repression to decapping.
MATERIALS AND METHODS
Protein expression and purification
S. cerevisiae Dhh130–425 and Dhh146–422 were cloned as
Tobacco etc virus (TEV)-cleavable His6-GST-tag fusion
proteins. They were expressed in BL21-Gold (DE3)
pLysS (Stratagene) in Terrific Broth medium. Cells were
resuspended in lysis buffer (20mM Tris, pH 7.4, 200mM
NaCl) supplemented with 10mM imidazole, DNase,
lysozyme and phenylmethylsulfonyl fluoride, and lysed
by sonication. Proteins (wild type and mutants) were
purified using Nickel-based affinity chromatography.
Point mutations were introduced by QuickChange site–
directed mutagenesis according to the manufacturer’s in-
struction (Stratagene). The His6-GST tag was either kept
or cleaved by overnight incubation with TEV. Proteins
were further purified by ion exchange chromatography
at pH 7.4 (Heparin, GE healthcare) followed by size-ex-
clusion chromatography (Superdex 75, GE Healthcare).
S. cerevisiae Pat11–30, Pat11–56, Pat11–114 and Pat15–79
proteins were expressed as TEV-cleavable GST-His-
tagged proteins in BL21-Gold (DE3) pLysS cells. The
cells were resuspended in lysis buffer and disrupted by
sonication. The proteins were purified by Nickel-based
affinity chromatography and then subjected (either
tagged or untagged following the addition of
TEV protease) to ion exchange chromatography at pH
8.0 (MonoQ 5/50, GE healthcare) and to size exclusion
chromatography (Superdex 75). For isothermal titration
calorimetry (ITC), Pat1 proteins were subcloned with a
His6-SUMO tag. S. cerevisiae Edc377–158 was subcloned
with His6-GST tag, while Edc377–158 and Edc377–116 were
subcloned as cleavable His6-SUMO proteins. All proteins
were expressed and purified following similar protocols
as the ones described above. For crystallization, the
His6-SUMO tag was cleaved using the SUMO protease
Senp2.
The complexes of yeast Dhh1 with Pat1 or Edc3 were
reconstituted by incubating the individually purified
proteins in a 1:1.5 molar ratio for 1 h at 4!C. Dhh1–
Pat1 and Dhh1–Edc3 were further purified by size exclu-
sion chromatography (Superdex 75) in a buffer containing
20mM Tris, pH 7.4, 150mM NaCl, 1mM DTT.
Crystallization and structure determination
Crystallization was carried out at 18!C using the vapor
diffusion method by mixing equal volumes of protein
complex at 27mg/ml and of crystallization buffer. The
best diffracting crystals of Dhh146–422 K234D, V238D
Pat15–79 complex were obtained in 50mM Tris, pH 8.0,
4% MPD, 200mM NaCl, 25% PEG 400 after 10 days.
Crystals were flash-frozen in liquid nitrogen directly from
the crystallization drop. Crystals of Dhh146–422 K234D,
V238D Edc377–158 were obtained with 50mM MES, pH
6.5, 5% PEG 400, 0.1M KCl, 10mM MgCl2. The crystals
were cryoprotected by adding glycerol and diffracted to
3.5 Å resolution (data not shown). Crystals of Dhh146–422
K234D, V238D and Edc377–116 were obtained at 19mg/ml
concentration of the complex and 50mM MES, pH 6.0,
10% MPD within 5 days. Crystals were flash-frozen by
adding 25% glycerol in the crystallization buffer and dif-
fracted to 3.25 Å resolution.
All diffraction data were collected at 100K at the
beamline PXII of the Swiss Light Source synchrotron
and processed using XDS. The structures were determined
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by molecular replacement with the program Phaser (48)
using the two RecA domains from the apo Dhh1 structure
(45) as search models. The atomic model was built with
the program Coot (49) and refined with PHENIX (50).
The data collection and refinement statistics are
summarized in Table 1.
In vitro pull-down assays
Experiments were performed by mixing 3 mg of GST-
tagged (bait) protein with equal molar amounts of
untagged (prey) protein. Binding buffer (20mM Hepes,
pH 7.5, 250mM NaCl, 2mM MgAc2, 10% glycerol,
2mM imidazole, 1mM DTT, 0.1 % Nonidet 40) was
added to a final volume of 60 ml. The reaction mixtures
were incubated on ice for 1–2 h. Fifteen microliters of 50%
(v/v) suspension of GSH–Sepharose beads in 200 ml of
binding buffer was added to each reaction mixture and
incubated at 4!C for 1 h. Beads were washed three times
with 500 ml binding buffer. Bound proteins were eluted
with 20mM reduced glutathione. Samples were separated
on sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and visualized by Coomassie blue
stain.
In vitro RNA-binding assays
The experiments were carried out essentially as previously
described (52). Single-stranded 50 biotinylated U20 RNA
(Dharmacon) was mixed with 3 mg of a given protein and/
or nucleotide in binding buffer (20mM Hepes, pH 7.5,
50mM NaCl, 10mM MgCl2, 1mM DTT, 10% glycerol,
0.1% Nonidet 40) to a final volume of 60ml and was kept
at 4!C overnight. Each reaction was then supplemented
with 200 ml of binding buffer and 50 mg of preblocked
magnetic streptavidin beads (Dynal) for 2 h, rocking at
4!C. Beads were washed three times with 500ml of
binding buffer. Proteins were eluted from the beads with
17 ml SDS loading buffer. Eluted samples were boiled for
5 min and analyzed on SDS-PAGE.
Isothermal titration calorimetry
Dhh130–425 and His6-SUMO tagged Pat15–56, Pat15–79 or
Pat15–114 proteins were dialyzed overnight in the same
buffer (20mM Hepes, pH 7.5, 150mM NaCl, 1mM
TCEP). ITC experiments were carried out at 25!C with
a VP-ITC Microcal calorimeter (Microcal, GE health-
care). The MicroCal cell was filled with Dhh130–425 at
17 mM concentration. For each titration, Pat1 was
injected into the cell 45 times in 10 ml volumes per injection
at the same intervals of time (5min). The concentration of
Pat1 in the syringe was "10 times the concentration of
the protein sample in the cell. The released heat was
obtained by integrating the calorimetric output curves
and was corrected for the effect of dilution by carrying
out a control experiment, titrating Pat1 against the
buffer in the cell. The Kd values and binding ratios were
calculated with the Origin (V7) software supplied with the
calorimeter. We used a similar protocol to measure the Kd
of Dhh130–425 and Edc377–158.
Co-immunoprecipitation assays
HEK293T cells were cultured in Dulbecco’s modified
Eagle medium containing 10% fetal bovine serum
(Gibco), 100U/ml penicillin and 0.1mg/ml streptomycin
(Gibco) at 37!C/5% CO2. Plasmids were transfected with
Table 1. Data collection and refinement statistics. The Ramachandran plot was calculated using the program
Molprobity (59)
Data set Dhh146–422 K234D,
V238D and Pat5–79
Dhh146–422 K234D,
V238D Edc377–116
Space group P4122 P4122
Cell dimensions
a, b, c (Å) 105.6, 105.6, 122.1 105.8, 105.8, 124.6
Data collection
Wavelength (Å) 0.9714 0.9796
Resolution (Å) 48.47–2.80 (2.90–2.80) 80.68–3.25 (3.36–3.25)
Rmerge (%) 7.6 (75.8) 9.2 (120.4)
I / !(I) 18.3 (2.8) 23.5 (2.4)
Completeness (%) 99.6 (96.17) 99.7 (97.47)
Multiplicity 6.8 17.3
Refinement
Resolution (Å) 53.11–2.80 53.70–3.25
No. of unique reflections 17 636 11 712
Rwork / Rfree (%) 20.42/24.71 20.85/24.57
Average B-factors (Å2) 48.30 105.60
No. of atoms
Proteins 3185 3115
Water 4
Stereochemistry
R.m.s.d. bond lengths (Å) 0.003 0.003
R.m.s.d. bond angles (!) 0.743 0.790
Ramachandran outliers (%) 0.00 0.25
Ramachandran favored (%) 97.51 98.25
Values in parentheses are for the highest-resolution shell.
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polyethyleneimine (Polysciences Inc., 1mg/ml) for protein
interaction studies. HEK293T cells were collected from
confluent 6-cm dish after 24 h of transient transfection.
Cells were lysed in 300ml of lysis buffer containing
10mM Tris, pH 7.5, 10mM NaCl, 10mM EDTA, 0.5%
Triton X-100 and protease inhibitors (Roche). Lysate was
centrifuged at 1000g for 5min at 4!C. Thirty microliters of
GFP binder protein sepharose beads were added to super-
natant for 1 h at 4!C. Beads were washed five times with
1ml of NET2 buffer (50mM Tris, pH 7.5, 150mM NaCl,
0.05% Triton X-100) and proteins were eluted with 40 ml
SDS sample buffer containing 5% b-mercaptoethanol.
Eluted proteins were run on 12% polyacrylamide gels
and transferred onto nitrocellulose membrane (0.45 mm
pore size) (Whatman Protran BA85) for western
blotting. Mouse monoclonal anti-GFP (Santa Cruz bio-
technology, sc-9996) and anti-HA (Covance, MMS-101R)
antibodies and horseradish peroxidase–coupled goat anti-
mouse (Millipore, AQ502A) secondary antibody were
used in combination with ECL prime western blotting de-
tection reagent (GE healthcare) for detection of HA- and
GFP-tagged proteins via western blotting.
Crosslinking–mass spectrometry analysis
The protein–RNA contacts site on Dhh1 were investigated
with mass spectrometry after UV-induced protein–RNA
crosslinking as described in (53). The purified crosslinks
were analyzed using Top10HCD method on an Orbitrap
Velos instrument and the data were analyzed using
OpenMS and OMSSA as a search engine (see Supplemen-
tary Methods).
RESULTS AND DISCUSSION
Biochemical and biophysical characterization of the yeast
Dhh1–Pat1 interaction
S. cerevisiae Pat1 is an 88 kDa protein containing an NTD
followed by a proline-rich region, a middle domain and a
C-terminal domain (20,22) (Figure 1A). Dhh1 contains
two RecA-like domains (RecA1 and RecA2) flanked by
N-terminal and C-terminal low-complexity regions (45)
(Figure 1A). The NTD of Pat1 is conserved from yeast
to humans and has been shown in the case of the D.
melanogaster and human proteins to mediate the inter-
action with the corresponding Dhh1 orthologues using
co-immunoprecipitation assays (22,23). This domain is
also part of a larger region found to strongly bind Dhh1
in the case of the yeast proteins (27).
To investigate the S. cerevisiae Dhh1–Pat1 complex, we
first narrowed down the interacting domains using pull-
down assays with recombinant Dhh1 and GST-tagged
Pat1 proteins. The NTD of yeast Pat1 (residues 1–114) ef-
ficiently precipitated the DEAD-box core of Dhh1 (residues
30–425, including RecA1 and RecA2) (Figure 1B, lane 9).
A segment of the Pat1 NTD that we engineered based on
evolutionary conservation (residues 1–56) was also able to
precipitate Dhh130–425 (Figure 1B, lane 8), while no binding
was observed when using a fragment of Pat1 encompassing
residues 1–30 (Figure 1B, lane 7). To experimentally
identify a Pat1 segment suitable for structural studies, we
purified the complex of Dhh130–425 and Pat11–114 and sub-
jected it to limited proteolysis. Treatment with the protease
chymotrypsin resulted in the accumulation of a fragment
that we characterized using mass spectrometry analysis and
N-terminal sequencing as corresponding to Pat1 residues
5–79 (Figure 1C).
Next, we assessed binding affinities quantitatively using
ITC. In the presence of 150mM salt, yeast Dhh130–425 and
Pat15–79 interacted with a Kd of "50 nM (Figure 1D, left
panel). A similar dissociation constant was obtained when
using Pat15–114 or Pat15–56 (Supplementary Figure S1),
indicating that most of the binding determinants
reside in the evolutionary conserved segment of the Pat1
NTD. Pat15–79 and the RecA2 domain of Dhh1 interacted
with a Kd of 32 nM (Figure 1D, central panel), while no
binding was detected with the RecA1 domain (Figure 1D,
right panel). We concluded that the Dhh1–Pat1 inter-
action is confined to the RecA2 domain of the DEAD-
box protein.
Crystal structure determination of a yeast Dhh1–Pat1
complex
Attempts to crystallize yeast Pat15–79 or Pat15–56 with the
RecA2 domain of Dhh1 failed, as the complexes appeared
to be too soluble to achieve the supersaturated conditions
required for nucleation. Complexes of Pat1 with
Dhh130–425 yielded the same crystal form that was previ-
ously reported for apo-Dhh1 (45), and indeed contained
only Dhh1. Inspection of this crystal form revealed that
the RecA2 domain of a Dhh1 molecule contacts the
RecA1 domain of a neighboring Dhh1 molecule in the
lattice (Supplementary Figure S2A). The surface of
RecA2 mediating crystal contacts is conserved and has
been shown in the case of the human orthologue DDX6
to bind the Phe-Asp-Phe (FDF) motif of Edc3 (35).
We reasoned that lattice contacts might promote the
dissociation of Pat1 from RecA2 during crystallization.
We therefore mutated the corresponding interacting
surface of the RecA1 domain (Supplementary Figure
S2), which did not contribute to Pat1 binding as
assessed by quantitative binding affinity measurements
(Figure 1D). For crystallization purposes, we introduced
the Lys234Asp, Val238Asp substitutions in Dhh146–422, a
construct that includes only the ordered polypeptide
region observed in the structure of apo Dhh130–425 (45).
Dhh146–422 K234D, V238D and Pat15–79 crystallized as a
complex and yielded crystals that diffracted to 2.8 Å reso-
lution. The structure was determined by molecular re-
placement and refined to an Rfree of 24.7%, Rwork of
20.6% and good stereochemistry (Table 1). The final
model consists of residues 46–421 of Dhh1 and residues
25–54 of Pat1 (hereafter referred to as Pat1N). No ordered
electron density was present for residues 5–24 and 55–79
of Pat1, consistent with the results from the binding assays
(Figure 1B, D and Supplementary Figure S1).
Overall structure of the yeast Dhh1–Pat1 core complex
In the complex we crystallized, Dhh1 adopts an open con-
formation (Figure 2). The relative orientation of the two
RecA domains is different from that observed in the
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Figure 1. Identification of the interacting regions of yeast Dhh1 and Pat1. (A) Schematic representation of the domain architecture of yeast Pat1
(in orange) and Dhh1 (in blue). The domain boundaries are derived from previous studies (45, 27, 22, 23) and from computational analysis. The
NTD of Pat1 refers to the segment upstream of the proline-rich (P-rich) segment. (B) Qualitative analysis of Dhh1-Pat1 interaction by GST pull-
down assays. Dhh130–425 was incubated with purified GST-tagged fragments of the Pat1 NTD (Pat11–114, Pat11–56, Pat11–30). One-sixth of the
reaction mixture was used as input and the bound fractions (precipitate) were analyzed on 4–20% SDS-NuPAGE Bis-Tris gels (Invitrogen). The
longest fragment of Pat1 NTD (Pat11–114) as well as Pat11–56 were precipitated Dhh130–425, while the shorter fragment Pat11–30 was unable to do so.
(C) Limited proteolysis experiment. The complex of Dhh130–425 and Pat11–114 was incubated at 0.6mg/ml with chymotrypsin (Roche) in a 1:10
(wt/wt) enzyme:protein ratio for 30min at 4!C. The products of the proteolysis were resolved on 17% SDS-PAGE gel. (D) Quantitative analysis of
Dhh1–Pat1 interaction by ITC. The MicroCal cell was filled with Dhh1 proteins at 17 mM and His6-SUMO-tagged Pat15–79 was injected at 150mM
concentration consecutively in 10 ml volumes. The three panels correspond to the ITC experiments with Dhh130–425 (RecA1-RecA2, left), with
Dhh1251–425 (RecA2, central) and with Dhh130–250 (RecA1, right). Shown in the insets are the number of calculated binding sites (N), and the
dissociation constant (Kd), as calculated with the program Origin.
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structure of wild-type apo Dhh1 (45) (Supplementary
Figure S2B). The difference probably arises from the mu-
tations we had introduced: an intramolecular interaction
between the two RecA domains observed in the structure
of the wild-type protein (a salt bridge between Lys234 and
Glu251) is impaired by the K234D mutation (Supplemen-
tary Figure S2B). In either conformation, the residues
mutated on RecA1 are at >40 Å distance from the
residues that bind Pat1N (Figure 2 and Supplementary
Figure S2B). Pat1N wraps around the RecA2 domain of
Dhh1, burying !10% (9118 Å2) of the solvent accessible
surface. Pat1N folds into an a-helical segment (residues
25–42) and an extended segment (residues 43–54)
(Figure 2).
An extended segment of yeast Pat1 docks onto the
FDF-binding site of Dhh1
The extended segment of yeast Pat1N contains a FDF
sequence motif (residues 51–53). The FDF motif binds
at a shallow surface pocket on the RecA2 domain of
yeast Dhh1 (that we refer to as the patch 1 surface)
formed by Ala263, Val265, Cys273, Leu277 and Ile409
(Figure 3A, central panel). The motif is recognized at
the same pocket and with the same conformation as
the DDX6-bound FDF motif of human Edc3 (patch 1,
Figure 3A, left panel) (35). Mutation of four residues sur-
rounding the FDF-binding site in D. melanogaster Me31b
has been previously shown by co-immunoprecipitation
studies to abolish Edc3 binding (35). We mutated the
equivalent residues at the patch 1 surface of yeast Dhh1
(Mut-1: Asn269Ala, His272Ala, Thr276Ala, Lys280Ala).
In pull-down assays with purified GST-tagged Pat15–79
and Dhh146–422 proteins, the binding of Pat1 to Mut-1
was decreased as compared with wild-type Dhh1
(Figure 3B, compare lanes 3 and 7).
In the case of human Edc3, the FDF motif is followed
by two helices that contain a conserved Phe-Asp-Lys
FDK motif and bind at a second surface patch (35)
(patch 2, Figure 3A, left panel). In the structure of yeast
Pat1N, there is no ordered extension C-terminal to the
FDF motif (Figure 3A, central panel), although this part
of the molecule is in principle present in the construct we
crystallized. We engineered a yeast Dhh1 mutant with sub-
stitutions at patch 2 (Mut-2: Phe393Ala, Tyr396Ala,
Glu399Ala, Gln400Ala) corresponding to the Me31b
mutant shown to abolish Edc3 binding in the case of the
D. melanogaster proteins (35). Consistently with the struc-
ture, yeast Pat15–79 was able to precipitate Mut-2 Dhh1
(Figure 3B, lane 6). As a control, we tested the Dhh1
mutants with yeast Edc377–158. This !80-residue long
segment of yeast Edc3 includes the equivalent !30-
residue long segment of human Edc3 that is ordered in
the structure with DDX6 (35) (Figure 4A). The Mut-1
and Mut-2 Dhh1 proteins failed to interact with
yeast Edc377–158 (Figure 3C, compare lane 3 with lanes
7 and 6). These results indicated that yeast Pat1 and
Edc3 compete for the same FDF-binding site on Dhh1
(patch 1). Yeast Pat1N, however, lacks the additional
Dhh1-binding segment at the C-terminus of the FDF
motif (patch 2) that is present in human and Drosophila
Edc3 (while absent in TraI) (35).
Figure 2. Structure of the yeast Dhh1–Pat1 core complex. The two RecA domains of Dhh1 are in blue. The Dhh1-binding domain of Pat1 spans
residues 24–54 (in orange). The structure is shown in two views related by a 90" rotation around a vertical axis. The N- and C-terminal residues
ordered in the structure are indicated. The two residues of RecA1 mutated for crystallization (K234D and V238D, shown in red) are far from the
RecA2 domain, where Pat1 binds.
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Figure 3. Hotspots of interactions on Dhh1. (A) The structure of Dhh1–Pat1 (central and right panel) is shown in comparison with the previously
determined structure of the RecA2 domain of human orthologue DDX6 (in gray) bound to another regulator, Edc3 (in salmon) (35) (left panel). The
structures in the central and left panels are in the same orientation relative to the RecA2 domain. The orientation of the Dhh1–Pat1 structure in the
right panel is related by rotations around a vertical and horizontal axis, as indicated. The close-up views show three hotspots of interactions on Dhh1
discussed in the text (patch 1, patch 2 and patch 3). Conserved residues involved in the interactions are shown in a ball-and-stick representation
(at patch 1 and patch 3 for Dhh1–Pat1, and at patch 1 and patch 2 for DDX6–Edc3). Patch 1 binds FDF motifs of yeast Pat1 and human Edc3.
Patch 2 binds the FDK motif of human Edc3 (35). Patch 3 binds an acidic segment of yeast Pat1. (B) Protein co-precipitations by GST pull-down
assays. The experiments were performed as described in Figure 1B after incubating yeast GST-tagged Pat15–79 with Dhh130–425 wild type or mutants.
Mut-1 corresponds to the N269A, H272A, T276A, K280A substitutions at Dhh1 patch1. Mut-2 corresponds to the F393A, Y396A, E399A, Q400A
at patch 2. Mut-3A corresponds to S292D, N294D and Mut3-B to R295D at patch 3. The Mut-1, Mut-3A and Mut-3B mutants of yeast Dhh1
decreased the interaction with Pat1 while Mut-2 did not, consistently with the structural analysis (Figure 3A, central and right panels). (C) Similar
pull-down experiments were performed with yeast GST-tagged Edc377–158 and Dhh130–425 wild type or mutants. The Mut-1, Mut-2, Mut-3A and
Mut-3B mutants of yeast Dhh1 all decreased the interaction with Edc3.
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The interaction at the FDF-binding site is conserved in the
human Pat1–DDX6 complex
Human and Drosophila Pat1 proteins do not contain a
FDF sequence motif. Structure-based sequence align-
ments, however, suggested the presence of an Asp-Trp
(DW) motif in metazoan Pat1 proteins at the correspond-
ing position of the yeast Pat1 FDF motif (Figure 4A). We
therefore tested whether the hydrophobic residue in the
DW motif of human Pat1b might dock on the FDF-
binding pocket of DDX6. We transiently co-expressed
full-length HA-tagged DDX6 and YFP-tagged Pat1b
residues 1–84 (hereby referred to as YFP-Pat1b) in
HEK293T cells and carried out co-immunoprecipitation
assays with GFP-binder beads. We found that a Trp46Ala
or a Trp46Asp substitution in YFP-Pat1b strongly
decreased the interaction with full-length HA-tagged
DDX6 (Figure 4B). The effect was similar to a Pat1-4A
mutant that has been recently shown to impair Dhh1
binding (54). In this assay, mutation of the FDF-binding
site in human HA-tagged DDX6 (Mut-1) significantly
decreased the interaction with YFP-Pat1b (Figure 4C).
We concluded that the interaction of Pat1 at the FDF-
binding site of Dhh1 is evolutionary conserved in yeast
and humans. Drosophila HPat is also expected to dock
at the FDF-binding site of Me31b (Figure 4A), but it is
possible that in this case the FDF-binding site contributes
less to the overall interaction, explaining previous co-
immunoprecipitation data (35).
An acidic helical segment of Pat1 docks onto a positively
charged surface of Dhh1
N-terminal to the FDF motif, Pat1N features a helical
segment that binds with extensive interactions at a third
surface patch on Dhh1 (patch 3, Figure 3A, right panel).
The helical segment of Pat1 is highly negatively charged
(Figure 4A) and binds to a positively charged surface of
Dhh1. Pat1 Asn34, Asn38, Thr41 and Asp45 make
polar contacts with Dhh1 Ser292, Asn294 and Arg295
(Figure 3A, right panel). In addition, Pat1 Glu33 forms
a salt bridge with Dhh1 Lys362 and Pat1 Phe42 makes
hydrophobic contacts with Dhh1 Leu298, Phe358 and
Arg295. The human Pat1b-4A mutant shown to disrupt
the interaction with DDX6 (54) (Figure 4B) maps to the
helical segment of Pat1 (alanine substitutions at Asp34,
Asp35, Thr36, Phe37, Figure 4A). We engineered muta-
tions in Dhh1 to disrupt patch 3. Substitutions of
Figure 4. Pat1 binds Dhh1 via evolutionary conserved residues. (A) Structure-based sequence alignment of Pat1 and Edc3 orthologues from
S. cerevisiae (Sc), Homo sapiens (Hs), D. melanogaster (Dm). Conserved residues are highlighted in orange for Pat1 and in salmon for Edc3. The
secondary structures (helices indicated as cylinders) are shown above and below the Pat1 and Edc3 sequences and correspond to the structures of the
yeast complexes reported in this manuscript. Conserved residues of yeast Pat1 and Edc3 that directly interact with Dhh1 are indicated with blue
circles and stars, respectively. (B) Co-immunoprecipitation assays of H. sapiens HA-tagged DDX6 with YFP-labeled Pat1b (residues 1–84). Wild type
and mutants (W46A, W46D and 4A) were transiently transfected in HEK293T cells. Trp46 of human Pat1b is predicted to reside at the corres-
ponding FDF motif of yeast Pat1 (panel A). The human 4A mutant corresponds to the D34, D35, T36 and F37 substitutions (53). Cell lysates
(input) were immunoprecipitated with GFP binder. HA-tagged and YFP-tagged proteins were detected by western blots. The Pat1b mutants (W46A,
W46D and 4A) impaired the interaction with wild-type DDX6. (C) Immunoprecipitation (IP) of wild-type YFP-tagged Pat1b (residues 1–84) with
HA-tagged DDX6 wild type, Mut-1 and Mut-3C. Mut-3C corresponds to the combined Mut-3A and Mut-3B substitutions (S343D, Q345D, R346D
in human DDX6). The IP was done as described above. The DDX6 mutants (Mut-1 and Mut-3C) impaired the interaction with wild-type Pat1b.
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Ser292Asp, Asn294Asp (Mut-3A) or of Arg295Asp (Mut-
3B) abolished binding to Pat15–79 in GST pull-down
assays (Figure 3B, lanes 4 and 5). The interacting
residues are conserved in the human orthologues. Indeed
a combined mutation of the Mut-3A and Mut-3B substi-
tutions in human DDX6 (Ser343Asp, Gln345Asp,
Arg346Asp or Mut-3C) impaired the interaction
with human Pat1 in co-immunoprecipitation assays
(Figure 4C).
Comparison of the structure of Dhh1–Pat1 with that of
the DEAD-box protein eIF4AIII in the exon junction
complex (EJC) (55,56) reveals that the patch 3 surface is
used in both DEAD-box proteins to recruit binding
partners (Supplementary Figure S3). The EJC is an
assembly formed by four proteins (eIF4AIII, Btz, Mago
and Y14), RNA and ATP (57). In the EJC, eIF4AIII
binds RNA with the two RecA domains in the typical
closed conformation observed in all known structures of
DEAD-box proteins in the active (RNA-ATP-bound)
state (55,56). Btz wraps around eIF4AIII and contributes
to RNA binding. The N-terminal segment of Btz contacts
RNA directly (via Phe188). In addition, Btz features
several positively charged residues (Arg176, Arg184 and
Arg185) that form a favorable electrostatic environment
for an incoming nucleic acid (Supplementary Figure S3).
The helical segment of Pat1N also approaches the
RNA-binding site expected for the ATP-bound conform-
ation, but features several surface-exposed negatively
charged residues (Glu28, Glu30, Glu32, Asp35, Asp39
and Glu40) that are predicted to electrostatically
disfavor binding of Dhh1 to nucleic acids (Supplementary
Figure S3).
Yeast Edc3 contains an acidic segment similar to Pat1
Originally as a control, we tested the Dhh1 patch 3
mutants with yeast Edc377–158 (Figure 3C). In the human
DDX6-Edc3 structure (35), there is no ordered segment
N-terminal to the FDF motif of Edc3 and therefore there
is no binding to the corresponding patch 3 surface of
DDX6. In pull-down assays, however, yeast Edc377–158
failed to interact with the Mut-3A and Mut-3B Dhh1
proteins (Figure 3C, lanes 4 and 5). As we could not ra-
tionalize these biochemical results based on the available
structural information, we set out to determine the crystal
structure of yeast Dhh1-Edc3. Yeast Dhh130–425 interacted
with Edc377–158 with a Kd of 200 nM (Supplementary
Figure S1B). The Edc377–158 construct is considerably
longer than the boundaries (residues 98–127) expected
from the structure of human Edc3 (35). Initial crystals
of the complex of yeast Dhh146–422 K234D, V238D and
Edc377–158 diffracted to 3.5 Å resolution. The electron
density map was of sufficient quality to show binding of
yeast Edc3 to patch 3 and to narrow down the domain
boundaries (i.e. no ordered electron density beyond
residue 116 of Edc3) (data not shown). We proceeded to
crystallize yeast Dhh146–422 K234D, V238D and
Edc377–116. The structure was determined at 3.25 Å reso-
lution with an Rfree of 24.6% and Rfactor of 21.0%. The
final model includes residues 46–420 of Dhh1 and residues
88–116 of yeast Edc3 (Figure 5A).
Comparison of the yeast Dhh1-Edc3 structure with that
of human DDX6-Edc3 shows a similar binding of the
FDF motif at the patch 1 surface. There is no equivalent
binding of a C-terminal helix to patch 2 (Figure 5A).
However, this is likely an artifact of crystallization, due
to a crystal contact that blocks Edc3 from accessing patch
2 of Dhh1. Indeed, binding of Dhh1 to yeast Edc377–158
was abolished by the patch 2 mutations (Figure 3C,
lane 6). More importantly, yeast Edc3 features an
ordered segment (residues 88–104) N-terminal to the
FDF motif (Figure 5A). In this segment, Trp91 of yeast
Edc3 binds in the same pocket of patch 3 as Phe42 of yeast
Pat1, explaining the results of the pull-down assays with
the patch 3 mutants (Figure 3C). Also similarly to yeast
Pat1, this segment of Edc3 is rich in negatively charged
residues (Figure 5B). While the N-terminal segment of
Pat1N is evolutionary conserved, the N-terminal segment
of yeast Edc3 is apparently not present in the human and
Drosophila orthologues. Indeed, the Mut-3C substitutions
in human DDX6 did not impair the interaction
with human Edc3 in co-immunoprecipitation assays
(Figure 5C). We concluded that these differences in the
structures of the orthologous complexes reflect genuine
differences in the interactions.
Pat1 and Edc3 disrupt RNA binding of Dhh1
We tested the effect of yeast Pat1 and Edc3 on the RNA-
binding properties of Dhh1 using a biotin-RNA pull-down
assay. In agreement with previous findings, Dhh130–425 was
precipitated by biotinylated RNA immobilized on
streptavidin beads even in the absence of nucleotide
analogs (Figure 6A, lanes 4 and 5) (44). On measuring
the affinity of Dhh130–425 for a U15 RNA by fluorescence
anisotropy, we found a Kd in the low micromolar range
(Supplementary Figure S4A), lower than that previously
reported for a full-length Dhh1 fusion protein (44), and
lower than that measured for Pat1 and Edc3 using ITC
(Figure 1D and Supplementary Figure S1). In the
presence of either Pat15–79, or Edc377–158, Dhh130–425
failed to bind to RNA in the pull-down assay (Figure 6A,
lanes 6,7 and lanes 8,9, respectively), suggesting that they
interfere with RNA binding.
Intrigued by the observation that there was no significant
difference in the RNA pull-down assays in the presence or
absence of ATP, we analyzed the nucleotide-binding
properties of Dhh1. First, inspection of the crystal structure
of apo Dhh1 (45) indicated that its closed conformation
is incompatible with ATP binding (Supplementary
Figure S4B). Dhh130–425 indeed did not bind ATP in ITC
experiments (Supplementary Figure S4C) and appeared to
be essentially inactive in RNA-dependent ATPase assays
(Supplementary Figure S4D), suggesting that Dhh1 is in
an enzymatically inactive conformation.
To map how this unusual DEAD-box protein can bind
RNA in the absence of ATP, we crosslinked Dhh130–425 to
a U15 RNA by subjecting the complex to UV irradiation at
254nm. We then used LC-MS/MS mass spectrometry to
detect and sequence peptides conjugated to the mass of an
RNA nucleotide [reviewed in (53)]. Using this approach, we
identified 6 tryptic peptides mapping to the RecA2 domain
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of Dhh1 (Figure 6B and Supplementary Figure S5). No
peptide was detected in the RecA1 domain, suggesting
that this domain is not able to bind RNA when Dhh1 is
in the enzymatically inactive conformation. However, the
flexible N-terminal region that precedes RecA1 might con-
tribute to RNA binding, as we detected an additional
peptide encompassing residues 32–44 (Supplementary
Figure S5). Within RecA2, two peptides mapped to the
canonical RNA-binding surface expected for the active
state of the DEAD-box protein (red and magenta patches
in Figure 6B). Others mapped to the outer surface of
RecA2 (green and yellow patches in Figure 6B), corres-
ponding to the patch 1 and patch 3 sites. The mass spec-
trometry analysis identified a direct crosslink between a
uridine nucleotide and Cys273 (Figure 6C), a residue in a
central position at the FDF-binding site on patch 1 (Figure
3A, central panel). Consistently, the electrostatic properties
of the RecA2 surface show patches of positive charges
along the RNA-binding surface mapped by mass-spectrom-
etry (Figure 6D). These data indicate that Dhh1 binds Pat1,
Edc3 and RNA with mutually exclusive interactions at
patch 1 and patch 3.
CONCLUSIONS
Dhh1 has a prominent pocket on the C-terminal RecA2
domain that recognizes short FDF linear motifs present in
both yeast Pat1 and Edc3. In the case of the human
orthologues, this pocket recognizes either the FDF motif
of Edc3 (35) or a DW motif in Pat1b. It is possible that
Dhh1 might bind other factors at this pocket, not neces-
sarily with a FDF motif in their sequence. A hydrophobic
pocket is present at the corresponding position in human
eIF4AIII, where it is used to bind a Tyr-containing short
linear motif of Upf3b (58). An analogous pocket is also
present in yeast eIF4A and is used to bind a Trp-contain-
ing short linear motif of eIF4G (59). Other DEAD-box
proteins might have evolved this structural feature to
recruit short motifs present in their binding factors.
While such hydrophobic pocket probably contributes
binding affinity, specificity is likely provided by binding
to additional surfaces. We note that binding of Pat1 or
Edc3 leaves a considerable surface area of Dhh1 unoccu-
pied and potentially available to other binding partners.
Because of their overlapping binding sites, Pat1 and
Edc3 cannot bind simultaneously on Dhh1. In addition,
they interfere with the RNA-binding properties of Dhh1.
Mapping the RNA-binding surfaces of Dhh1 by a
crosslinking–mass spectrometry approach suggests that
RNA wraps around the RecA2 domain, docking also at
the FDF-binding site of Dhh1 (at patch 1). In this con-
formation, in the absence of ATP, Dhh1 is in an
enzymatically inactive state. The presence of both ATP
and RNA appears to be insufficient to release the
inactive conformation of Dhh1 that arises from the stabil-
ization of an unproductive conformation of the two RecA
Figure 5. The interaction of Dhh1 and Edc3. (A) The structure of the yeast Dhh1–Edc3 core complex is shown in a similar orientation as in
Figure 3A. The two RecA domains of yeast Dhh1 are in blue and Edc3 residues 88–116 are in salmon. The two residues on RecA1 mutated for
crystallization purposes are highlighted in red. (B) Close-up view of the negatively charged residues of yeast Edc3 lining the patch 3 surface of Dhh1.
(C) Co-immunoprecipitation assays of human YFP-tagged Edc3 and HA-tagged DDX6 wild type, Mut-1 or Mut-3C were carried out as described in
Figure 4C. With the human proteins, mutations at patch 3 (Mut-3C) do not abrogate binding.
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Figure 6. Pat1 and Edc3 compete with RNA for binding to Dhh1. (A) Co-precipitation of 50 biotinylated single-stranded poly-U20 RNA with yeast
Dhh1 alone or in complex with Pat15–79 or Edc377–158. The pull-down experiments were performed with streptavidin beads [essentially as described in
(51)] and analyzed on 4–20% NuPAGE Bis-Tris gels (Invitrogen) using 20% of the total as input and bound samples. Dhh1 bound to RNA in
presence or absence of nucleotides, as previously reported (44,39). In the presence of either Pat15–79 or Edc377–158, Dhh1 binding to RNA was
impaired. (B) On the left are the peptides of RecA2 identified by mass spectrometry analysis to be crosslinked to RNA (Supplementary Figure S5).
On the right, surface representation of apo Dhh1 (45) (in light blue) with the RNA-crosslinked peptides shown in the same colors as on the right.
Shown in black is the RNA modeled after superposition with eIF4AIII-AMPNP-RNA in EJC structure upon superposition of the RecA2 domains
(54,55). Notice that, in this conformation of Dhh1, an RNA bound in the typical ATP-dependent conformation would sterically clash against the
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domains by an extensive network of intramolecular inter-
actions (44,45). Pat1 and in yeast Edc3 are expected also
to approach the canonical ATP-dependent RNA-binding
surface (at patch 3) with a negatively charged segment,
and thus to interfere with it.
The results predict that Pat1, Edc3 and RNA bind
Dhh1 as separate steps in the pathway, pointing to the
presence of transitions in the architecture of an mRNP
as it gets targeted to decay. A working model for the
sequence and coordination of these structural rearrange-
ments is outlined below. In the cytoplasm, Dhh1 is present
in large excess and binds mRNAs in a constitutive, ATP-
independent manner (39,44,45). We envision that upon
triggering translational repression and deadenylation,
Pat1 and Edc3 binding to Dhh1 would release it from
the nonproductive ATP-independent mode of RNA
binding. This displacement would allow Dhh1 to bind
RNA in a productive ATP-dependent manner, triggering
ATP hydrolysis and dissociation from the mRNP. This
step is likely to require the binding of an activator to
release Dhh1 from the enzymatically inhibited conform-
ation. Besides the Dhh1-binding domain, Pat1 and Edc3
bridge to the Lsm complex and to the decapping complex,
respectively. Discovering the precise sequel of events that
lead to the swap between Pat1-containing and Edc3-con-
taining complexes on Dhh1 as well as the identity of the
Dhh1 activator are quests for future studies.
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Supplementary Figures 
 
Figure S1 
Quantitative analysis of yeast Dhh1-Pat1 and Dhh1-Edc3 interaction 
(A) Isothermal titration calorimetry (ITC) of Dhh130-425 with His-SUMO-Pat15-56 and 
Pat15-114. Experiments were performed as described for Figure 1D. 
(B) ITC of Dhh130-425 with His-SUMO-Edc377-158. Experiments were performed as 
described for Figure 1D. 
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Figure S2 
Intermolecular and intramolecular Dhh1 interactions in the crystals 
(A) The close-up view shows the crystal lattice contacts of yeast Dhh1 wild-type 
crystals (45). The RecA2 domain of one Dhh1 molecule (in blue) interacts with the 
RecA1 domain of a neighbouring one (in gray), at the so-called FDF-binding site 
(patch1). The residues of RecA1 mutated for crystallization of the yeast Dhh1-Pat1 
and Dhh1-Edc3 complexes are highlighted in red.  
(B) The crystal structure of wild-type Dhh1 in the unbound state (45) is shown on the 
right, in the same orientation as the structure of the yeast Dhh1 K234D, V238D 
mutant in complex with Pat1 (on the left) after superposition of the RecA2 domains. 
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On the right, the intramolecular interaction of K234 (on RecA1) and E251 (on 
RecA2) is highlighted. This interaction is impaired in the mutant we have used for 
crystallizing the complexes.  
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Figure S3 
Different DEAD-box proteins use the patch 3 surface to bind regulators  
Close-up views of the negatively-charged residues of yeast Pat1 lining the patch 3 
surface of Dhh1 (left panel). The right panel shows the structure of human eIF4AIII 
(gray), Btz (red) and RNA (in black) extracted from the structure of the EJC (54, 55) 
and viewed in the same orientation as the structure in the left panel, after 
superposition of the RecA2 domains. Positively-charged residues of Btz line the 
corresponding patch 3 surface of eIF4AIII and approach the RNA-binding site. 
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Supplementary Figure S4 
RNA-binding and nucleotide-binding properties of the Dhh1 DEAD-box core 
(A) Quantitative analysis of Dhh130-425 binding to a U15 RNA by fluorescence 
anisotropy (FA). FA measurements were performed with a 5'-6-carboxy-fluorescein 
(6-FAM)-labeled U15 RNA at 20°C on a Genios Pro (Tecan) using 50µl-reactions. 
The RNA was dissolved to a concentration of 9.6 nM and incubated with Dhh130-425 at 
different concentrations in 25mM MOPS pH 7.0, 150 mM NaCl, 10mM MgCl2 and 
2mM β-mercaptoethanol. The excitation and emission wavelengths were 485nm and 
535 nm, respectively. Each titration point was measured three times using ten reads 
      48 
with an integration time of 40 µs. The data were analyzed using nonlinear regression 
fitting using the Origin software. 
(B) Surface representation of apo Dhh1 with an ATP analogue modeled from the 
Dbp5-AMPPNP-RNA structure (60) after superposition of the RecA2 domains. Only 
the α-phosphate of ATP  (in red) is in principle accessible in this closed conformation 
of Dhh1. 
(C) ITC of Dhh130-425 with ATP. Experiments were performed as described as for 
Figure 1D. 
(D) ATPase assays performed in the presence of a U25 RNA with Dhh130-425 either 
alone (blue diamonds) or in complex with Pat15-79 (brown triangles). The activity of 
Ski2 (61) is shown as a control (orange circles). The data represent mean values and 
standard deviations from three independent experiments. The measurements were 
carried out as reported in (61). 
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Figure S5 
Dhh1-RNA crosslinking and mass spectrometry analysis 
MS/MS spectra of Dhh1 peptides with an additional mass that corresponds to uracil 
nucleotides. Peptide sequence and the fragment ions are indicated on the top. The 
crosslinked residues are highlighted in yellow. The peptide fragmentation occurs with 
      50 
the cleavage of amide bonds resulting in b-ions and y-ions when the charge is retained 
by the amino-terminal and carboxy-terminal fragments, respectively. Asterisk (*) and 
hash (#) indicate the ions that were observed with a mass shift corresponding to U-
H3PO4 and –C3O (a 52 Da fragment of Uracil), respectively. IM: Immonium ions. U’: 
U marker ion of 113.03 Da. 
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Supplementary Methods 
 
UV induced Protein-RNA crosslinking and enrichment of cross-linked peptides 
UV cross-linking and enrichment of cross-linked peptides was performed according 
to the established protocols described in (62). Briefly, 1 nmol of the single stranded 
U15 RNA oligonucleotide and 1 nmole of Dhh130-425 were mixed in a 1:1 molar ratio 
and the total reaction volume was made up to 100 µl in 20 mM HEPES pH 7.5, 
50 mM NaCl, 2 mM DTT and 5 mM EDTA. The mixture was incubated on ice 
overnight. The samples were then transferred to black polypropylene microplates 
(Greiner Bio-One) and irradiated at 254 nm for 10 minutes. After ethanol 
precipitation the samples were denatured in 4M Urea, 50 mM Tris-HCl pH 7.9 and 
digested for 2 hours at 52°C with 1 µg RNase A (Ambion, Applied Biosystems). 
Following RNA digestion, proteolysis with trypsin (Promega) was performed 
overnight at 37°C. The sample was desalted on an in-house prepared C18 (Dr. Maisch 
GmbH) column and the cross-linked peptides were enriched on an in-house prepared 
TiO2 (GL Sciences) column using the protocol described in (62). The samples were 
dried and then resuspended in 10 µl sample solvent (5% v/v ACN, 1% v/v FA) for 
mass spectrometry analysis. 
 
Nano-liquid chromatography and MS analysis  
5 µL of the above sample was injected onto a nano-liquid chromatography system 
(Agilent 1100 series, Agilent Technologies) including a C18 trapping column of 
length ~2 cm and inner diameter 150 µm, in-line with a C18 analytical column of 
length ~15 cm and inner diameter 75 µm (both packed in-house, C18 AQ 120 Å 5 
µm, Dr. Maisch GmbH). Analytes were loaded on the trapping column at a flow rate 
of 10 µL/min in buffer A (0.1% v/v FA) and subsequently eluted and separated on the 
analytical column with a gradient of 7–38% buffer B (95% v/v acetonitrile, 0.1% v/v 
FA) with an elution time of 33 min (0.87%/min) and a flow rate of 300 nL/min. 
Online ESI-MS was performed with an LTQ-Orbitrap Velos instrument (Thermo 
Scientific), operated in data-dependent mode using a TOP10 method. MS scans were 
recorded in the m/z range of 350-1600 and for subsequent MS/MS top 10 most 
intense ions were selected. Both Precursor ions as well as fragment ions were scanned 
in the Orbitrap. Fragment ions were generated by HCD activation (higher energy 
collision dissociation, normalized collision energy=40), and recorded from m/z=100. 
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As precursor ions as well as fragment ions were scanned in the Orbitrap, the resulting 
spectra were measured with high accuracy (< 5 ppm) both in the MS and MSMS 
level. 
 
Data analysis 
The MS .raw files were converted into the .mzML format with msconvert (63). 
Protein-RNA cross-links were analyzed using OpenMS (64, 65) and OMSSA (66) as 
search engine. Data analysis workflows were assembled based on (66). The high 
scoring cross-linked peptides were manually annotated for confirmation. Protein RNA 
interactions between the N1T25LP complex and polyU RNA was analyzed with UV 
induced protein-RNA crosslinking followed by mass spectrometry. Seven peptides of 
Dhh1 protein were observed carrying an additional mass corresponding to Uracil 
nucleotides.  
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In this section, the research article published in the journal Cell Reports (Volume 5, 
Issue 2, Pages 283-291, published on October 31, 2013) is presented as it was 
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SUMMARY
The decay of mRNAs is a key step in eukaryotic gene
expression. The cytoplasmic Lsm1-7-Pat1 complex
is a conserved component of the 50-to-30 mRNA
decay pathway, linking deadenylation to decapping.
Lsm1-7 is similar to the nuclear Sm complexes that
bind oligo-uridine tracts in snRNAs. The 2.3 Å resolu-
tion structure ofS. cerevisiaeLsm1-7 shows thepres-
ence of a heptameric ring with Lsm1-2-3-6-5-7-4
topology. A distinct structural feature of the cyto-
plasmic Lsm ring is the C-terminal extension of
Lsm1, which plugs the exit site of the central channel
and approaches the RNA binding pockets. The 3.7 Å
resolution structure of Lsm1-7 bound to the C-termi-
nal domain of Pat1 reveals that Pat1 recognition is not
mediated by the distinguishing cytoplasmic subunit,
Lsm1, but by Lsm2 and Lsm3. These results show
how the auxiliary domains and the canonical Sm folds
of the Lsm1-7 complex are organized in order to
mediate and modulate macromolecular interactions.
INTRODUCTION
RNA degradation modulates the steady-state levels of cellular
transcripts and has emerged as a powerful mechanism for
altering the abundance of proteins in response to changes in
physiological conditions (reviewed in Schoenberg and Maquat,
2012). In eukaryotes, cytoplasmic mRNA turnover generally
starts with the shortening of the poly(A) tail at the 30 end of the
message (reviewed in Chen and Shyu, 2011). The short stretch
of adenosines that is left by the action of the deadenylases
(Ccr4-Not and Pan2-Pan3) is the foothold for initiating two alter-
native decay pathways: the degradation of the RNA body in the
30-to-50 direction (via the exosome-Ski complex) or the removal
of the 50 cap structure and degradation in the 50-to-30 direction
(via the decapping factors and Xrn1) (reviewed in Garneau
et al., 2007). Genetic, biochemical, and structural data have
shown that the core enzymes and regulators in mRNA turnover
are evolutionarily conserved and have revealed the presence
of intricate interaction networks (see the reviews above).
The conserved Lsm1-7-Pat1 complex plays an important role
in coupling deadenylation and decapping in the 50-to-30 decay
pathway (Bouveret et al., 2000; Tharun et al., 2000, Tharun,
2009; Haas et al., 2010; Ozgur et al., 2010; Totaro et al., 2011).
Lsm1-7-Pat1 preferentially associates with the 30 end of oligoa-
denylated mRNAs in vivo (Tharun et al., 2000; Tharun and
Parker, 2001), protecting the last 20–30 nucleotides of the mes-
sage (He and Parker, 2001). Lsm1-7-Pat1 subunits are required
for normal rates of decapping in vivo (Bouveret et al., 2000;
Tharun et al., 2000) and colocalize to discrete cytoplasmic foci
known as P bodies along with all other 50-to-30 decay factors
(Tharun et al., 2000; Pilkington and Parker, 2008; Haas et al.,
2010; Ozgur et al., 2010). Lsm1-7 is composed of seven Sm-
like proteins (numbered 1–7) and is related to the nuclear Sm
complexes involved in binding small nuclear RNAs (snRNAs) (re-
viewed inWilusz andWilusz, 2005). Pat1 is a multifunctional pro-
tein. It binds the decapping complex Dcp1-Dcp2 (Pilkington and
Parker, 2008; Braun et al., 2010; Nissan et al., 2010; Ozgur et al.,
2010) as well as another decapping activator, Dhh1 (DDX6)
(Braun et al., 2010; Haas et al., 2010; Nissan et al., 2010; Ozgur
et al., 2010; Sharif et al., 2013). Pat1 has also been shown to
interact with the Xrn1 exoribonuclease in yeast (Bouveret
et al., 2000; Nissan et al., 2010) and with the Ccr4-Not deadeny-
lase in Drosophila (Haas et al., 2010). Although many of these in-
teractions are likely to be transient, the association of Pat1 with
Lsm1-7 is sufficiently stable to allow the purification of the
endogenous octameric complex from yeast (Bouveret et al.,
2000; Chowdhury et al., 2007). In vitro, Lsm1-7-Pat1 binds
directly polyuridine oligonucleotides with enhanced affinity
when flanked by a short oligo-adenosine tail (Chowdhury et al.,
2007). In yeast, Lsm1-7-Pat1 preferentially binds short oligo-uri-
dine stretches located close to the 30 end of endogenous
mRNAs (Chowdhury et al., 2007; Mitchell et al., 2013).
Sm folds are uridine-specific RNA binding domains (Achsel
et al., 2001). Structural studies have revealed how nuclear Sm
complexes assemble into heteroheptameric rings around
specific U-rich sequences of the U1 and U4 snRNAs (Pomeranz
Krummel et al., 2009; Weber et al., 2010; Leung et al., 2011). In
contrast to the spliceosomal Sm proteins, the two canonical
Lsm complexes (Lsm1-7 and Lsm2-8) form rings spontaneously
in the absence of RNA (Achsel et al., 1999; Salgado-Garrido
et al., 1999). The cytoplasmic Lsm1-7 and the nuclear Lsm2-8
complexes share six of their seven subunits (reviewed in Wilusz
and Wilusz, 2005). The distinguishing cytoplasmic subunit
Lsm1 harbors critical determinants for the RNA binding
properties of the complex not only in the canonical Sm domain
but also in the distinctive C-terminal domain (Tharun et al.,
Cell Reports 5, 283–291, October 31, 2013 ª2013 The Authors 283
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2005; Chowdhury and Tharun, 2008; Chowdhury et al., 2012).
The expectation is that Lsm1 might also specify other cyto-
plasmic-specific interactions. In this work, we address how the
Sm folds and the distinct auxiliary domains of Lsm1-7 are struc-
tured and how they mediate the interaction with Pat1.
RESULTS AND DISCUSSION
Reconstitution of a Recombinant Lsm1-7-Pat1 Core
Complex
The Lsm1–Lsm7 proteins contain a central Sm-like domain
flanked by N-terminal and C-terminal extensions (Figure 1A).
Figure 1. Structural Analysis of Lsm1-7 and
Lsm1-7-Pat1 Complexes
(A) A schematic representation of the domain ar-
rangements of the yeast Lsm1-7 and Pat1 pro-
teins. Color-filled rectangles highlight the Sm folds
of the Lsm proteins and the folded domain of Pat1.
Dashed rectangles highlight the C-terminal ex-
tensions of Lsm1 and Lsm2. The residue numbers
indicate the constructs used in this study.
(B) A table with data collection and refinement
statistics. Values for the highest-resolution shell
are given in parenthesis. Structure validation was
carried out with Molprobity (Chen et al., 2010).
The Lsm1-7 complex is expected to be
formed by hetero-oligomeric building
blocks similar to those of the nuclear
Sm complex, and Lsm2-3 corresponds
to SmD1-D2, Lsm6-5-7 to SmF-E-G,
and Lsm4-1 to SmD3/B (Kambach et al.,
1999; Raker et al., 1999; Salgado-Garrido
et al., 1999; Bouveret et al., 2000; Zaric
et al., 2005; Mund et al., 2011). We
obtained recombinant S. cerevisiae
Lsm2-3 and Lsm5-6-7 from coexpres-
sion constructs (a gift of K. Nagai and Y.
Kondo). S. cerevisiae Lsm1 and Lsm4
were expressed individually. In the latter
case, the polypeptide (residues 1–114,
hereby referred to as Lsm4) lacked the
long Q- and N-rich C-terminal extension
(Figure 1A). This region of Lsm4 is proteo-
lytically sensitive in vitro (K. Nagai and
Y. Kondo, personal communication) and
is not required for normal mRNA decay
rates in vivo (Decker et al., 2007). Recon-
stitution of the Lsm1-7 complex included
a mild denaturing step (Zaric et al., 2005)
that most likely overcomes the tendency
of these proteins to oligomerize unspe-
cifically when at high concentrations
in vitro.
S. cerevisiae Pat1 (796 residues) is a
multidomain protein with N-terminal, pro-
line-rich, Mid, and C-terminal domains
(Figure 1A) (Haas et al., 2010; Nissan et al., 2010). The C-terminal
domain is required and sufficient to bind Lsm1-7 in both yeast
(Nissan et al., 2010) and humans (Braun et al., 2010). The Mid
domain has also been shown to contribute to Lsm1-7 binding
(Pilkington and Parker, 2008; Braun et al., 2010) and, in the
case of the Drosophila ortholog, provides a major interaction
site (Haas et al., 2010). We expressed and purified a portion
of S. cerevisiae Pat1 including both the Mid and C-terminal
domains (residues 220–796), formed a complex with the recon-
stituted Lsm1-7, and subjected the octameric assembly to
limited proteolysis (Figure S1A). Treatment with the protease
elastase resulted in the accumulation of truncated Pat1 and
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Lsm1 proteins, whereas all other subunits of the complex re-
mained stable (Figure S1A). N-terminal sequencing and mass
spectrometry analysis mapped the proteolytic fragment of Pat1
to the C-terminal domain (residues 450–796, hereby referred to
as Pat1C). Full-length Lsm1 (172 residues) was proteolyzed
into different fragments that started at residues 27 or 45 and
ended at residues 145 or 159. Previous studies have shown
that the N-terminal extension of Lsm1 is functionally dispensable
in yeast (Tharun et al., 2005). In contrast, the conserved C-termi-
nal extension (also known as C-terminal domain or CTD) is
required for RNA binding in vitro and for Lsm1 function in vivo
(Tharun et al., 2005; Chowdhury et al., 2012). Therefore, we
engineered a construct of Lsm1 containing residues 27–172
(referred to as Lsm1A) and purified the corresponding Lsm1A-7
and Lsm1A-7-Pat1C complexes for structural analysis.
Lsm1-7 Is an Sm-like Heptameric Ring
We obtained crystals of yeast Lsm1A-7 diffracting at 2.3 Å reso-
lution and solved the structure by molecular replacement with
the coordinates of known Sm-like rings (Leung et al., 2011;
Mund et al., 2011). The final model is refined to an Rfree of
25.8% and an Rwork of 21.1% with good stereochemistry (Fig-
ures 1B and S1B). The model includes most of the polypeptide
chains (see the Supplemental Information) and, in addition, in-
cludes ten residues of the tag engineered in Lsm2 for purification
purposes (Figure 2A). Each of the seven Lsm proteins contains
the characteristic Sm fold, a b barrel of five antiparallel and highly
bent b strands with an N-terminal a helix (helix a1) on top. The
seven Sm domains pack side by side in a ring-like architecture
with a flat surface on top (the so-called proximal face, where
the a helix is positioned) and the so-called tapered or distal
surface at the bottom (Figure 2A). The overall oligomeric struc-
ture of the Lsm1-7 ring is generally similar to that of the nuclear
U4 snRNP core (Leung et al., 2011). The oligomerization is based
on the same repeating principle, namely the b4 strand of one
subunit packing against the b5 strand of the neighboring subunit
(Figure 2A, left). This results in an intermolecular b sheet that
scaffolds the ring via extensive hydrophobic contacts.
The order of the subunits in the ring is Lsm1-2-3-6-5-7-4, as
predicted previously (Kambach et al., 1999; Raker et al., 1999;
Salgado-Garrido et al., 1999; Bouveret et al., 2000; Zaric et al.,
2005; Mund et al., 2011) (Figure 2A, left). Specificity in the
hetero-oligomerization is dictated by subunit-specific inter-
actions, typically electrostatic contacts along the outer and inner
circumferences of the ring. Several conserved electrostatic pairs
are observed within the Lsm2-3 and Lsm6-5-7 building blocks
(for example, Glu18Lsm2-Arg61Lsm3, Asp22Lsm2-Arg24Lsm3, and
Glu29Lsm5-Arg87Lsm7) (Figures 2B and S2). In addition,
conserved electrostatic pairs also occur between building
blocks (for example, Lys19Lsm3-Glu54Lsm6, Lys41Lsm7-
Glu23Lsm4, and Arg62Lsm1-Glu48Lsm4) (Figures 2B and S2) and
most likely contribute to the ability of the Lsm subunits to
assemble in a preformed ring without the need of an RNA mole-
cule to nucleate hetero-oligomerization (Achsel et al., 1999; Sal-
gado-Garrido et al., 1999). We note that the corresponding Sm
building blocks lack some of the charged pairs at the equivalent
positions, suggesting why mixed assemblies of Sm and Lsm
proteins might not be favored.
The Lsm1-7 Ring Is Complemented by the Distinct
C-Terminal Extensions of Lsm1 and Lsm2
The Lsm1-7 ring has distinct structural features in comparison to
known Sm rings. First, the C-terminal extension of Lsm2 (resi-
dues 72–94) forms a short a helix (a2) that lies on the proximal
face of the ring between the a1 helices of Lsm2 and Lsm3 (Fig-
ure 2A, right). The second and most striking feature is the C-ter-
minal extension of Lsm1 (residues 115–172). This domain starts
at the proximal face of the ring, wraps around the outer surface of
the Lsm1 b barrel with a short a helix (a2), and reaches the distal
face (Figure 2A, right). Here, it forms a long a helix (a3) that tra-
verses the diameter of the ring, interacting with Lsm1 and
Lsm4 on one side and with Lsm3 and Lsm6 on the other (Fig-
ure 2A, left). Then, the polypeptide makes a sharp bend (at the
conserved Gly162) and stretches in an antiparallel fashion on
top of helix a3 (Figure 3, left). Several evolutionarily conserved in-
teractions hook the very C terminus of Lsm1 inside the ring;
Tyr172Lsm1 fits in a pocket created between Lsm1 and Lsm4,
whereas Asp170Lsm1 interacts electrostatically with Arg59Lsm1.
The extensive interactions we observe in the structure rationalize
why the C-terminal extension of Lsm1 is able to function even
when in trans (Chowdhury et al., 2012).
Deletion of the C-terminal extension of Lsm1 has been shown
to decrease the RNA binding affinity of the complex but not to
prevent the specific recognition of U tracts (Chowdhury et al.,
2012). Superposition of the Lsm1A-7 structure with that of the
U4 snRNP core (Leung et al., 2011) allowed us to examine the
putative RNA binding path (Figure 3). In the nuclear Sm complex,
RNA binds at the consecutive uridine binding pockets that line
the inner circumference of the ring and then threads through
the entire central channel to exit with the 30 end at the distal
surface (Leung et al., 2011) (Figure 3, right). The uridine-binding
pockets are created by the so-called Sm1 and Sm2 sequence
motifs and are also present in Lsm1-7 (Figure 2B). Therefore,
the Lsm proteins are expected to engage U bases with stacking
and hydrogen-bonding interactions similar to those observed in
the nuclear Sm complex (Leung et al., 2011). In contrast, RNA
cannot exit the Lsm1-7 ring with the same path observed in
the U4 snRNP structure because it would clash against the
C-terminal extension of Lsm1 (Figures 3 and S3). It is possible
that, although it poses considerable steric hindrance at the exit
site of the channel, the Lsm1 extension might still allow the
RNA 30 end to thread through a narrow hole leading to the distal
face of the ring. However, it is also possible that the C-terminal
extension prevents the RNA from threading through the entire
channel. In this case, we note that the unhindered part of the
channel would be able to fit two to three additional nucleotides
after the last uridine expected from the U4 snRNP structure
(U836) (Figure 3).
The Pat1 C-Terminal Domain Protrudes on the Side of
the Lsm1-7 Ring
Next, we addressed how Lsm1-7 binds Pat1. The Lsm1A-7-
Pat1C complex yielded diffracting crystals, but we found that
only Lsm1A-7 was present in the asymmetric unit. Inspection of
the lattice suggested the presence of a possibly unfavorable
crystal contact involving the C-terminal extension of Lsm1.
Given that the Lsm1 C-terminal extension is not required for
Cell Reports 5, 283–291, October 31, 2013 ª2013 The Authors 285
      58 
 
(legend on next page)
286 Cell Reports 5, 283–291, October 31, 2013 ª2013 The Authors
3.2 Architecture of the Lsm1-7-Pat1 complex 
 
59 
the assembly of the Lsm ring or Pat1 binding (Chowdhury et al.,
2012), we generated an Lsm1 construct encompassing residues
45–145 (referred to as Lsm1B), which corresponds to its smallest
proteolytic fragment (Figure S1A). The Lsm1B-7-Pat1C complex
yielded crystals diffracting to 3.7 Å resolution. We solved the
structure bymolecular replacement using Lsm1A-7 and a homol-
ogy model of Pat1C based on the crystal structure of the human
ortholog previously crystallized in isolation (Braun et al., 2010).
The structure is refined to an Rfree of 29.5% and an Rwork of
24.9% with good stereochemistry (Figures 1B and S1B). The
final model includes essentially all the residues of Lsm1B-7 and
residues 471–783 of Pat1.
S. cerevisiae Pat1C is an elongated domain formed by helical
hairpins related to the ARM repeat and HEAT repeat family of
proteins (Figures 4A and S4A). Each hairpin is composed of
two antiparallel a helices (termed A and B) connected by loops
or additional helical segments (Andrade et al., 2001). The hair-
pins pack side by sidewith a right-handed twist, forming a super-
helix with a layer of six A helices on one side and a layer of five B
helices on the other. However, the hairpins of PatC are rather
irregular in both length and curvature. A comparison of the struc-
ture of yeast Pat1C with that of the human ortholog (Braun et al.,
2010) shows that the first four hairpins are very similar, whereas
the last two differ substantially in the position and orientation of
the individual helices (Figure S4B). The Pat1C superhelix binds
with the N-terminal repeats to the outer surface of Lsm1-7 and
projects into solvent, the last hairpin being positioned more
than 40 Å away from Lsm1-7 (Figure 4A).
Figure 2. Canonical and Idiosyncratic Features of the Lsm1-7 Ring
(A) The crystal structure of S. cerevisiae Lsm1A-7 is shown in two orientations related by a 90! rotation around a horizontal axis. In the left panel, the complex is
viewed on the distal face. The b4 and b5 strands of each subunit are labeled. The right panel is a side view of the complex. The N-terminal helices (a1 and a2) in the
C-terminal extension of Lsm2 are labeled as well as the helices in the C-terminal extension of Lsm1 (a2 and a3). The additional residues of the Lsm2 tag are
highlighted in gray in the right panel.
(B) Structure-based sequence alignment of Lsm1-7 orthologs from S. cerevisiae (Sc), H. sapiens (Hs), and D. melanogaster (Dm). Conserved residues are in
colored boxes. In black are the central residues of the Sm1 motif (the D-x-F-x-N sequence, F being a hydrophobic residue) and the Sm2 motif (the R-G
sequence). The canonical secondary structures of the Sm cores are above the sequences. The additional helices in the extensions of Lsm1 and Lsm2 are boxed
around the corresponding sequences.
Figure 3. The C-Terminal Extension of Lsm1 Obstructs the RNA Exit Site
The C-terminal extension of Lsm1 binds in the central channel. On the left, a zoom-in of the Lsm1A-7 structure is shown in the same orientation as in the left panel
of Figure 2A. On the right is the corresponding zoom-in view of the U4 snRNP core structure (Leung et al., 2011) after optimal superposition of the Sm subunits,
and RNA is shown in black. The Asp and Asn residues of the Sm1motif and the Arg residue of the Sm2motif indicate the position of the uridine-binding pocket of
Lsm7 (left) and SmG (right). Lsm2-3 and SmD1-D2 have been removed for clarity. The Lsm1 C-terminal extension is 12–15 Å away from the corresponding
position of U836 in the U4 snRNP structure and would clash against a nucleotide at the corresponding position of A840.
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Figure 4. Pat1C Binds the Lsm1-7 Ring at Lsm2 and Lsm3
(A) Structure of Lsm1B-7-Pat1C viewed with the ring in the same orientation and colors as in Figure 2A, left. Pat1 is shown in green, and the interacting helices of
the HEAT-repeat-like superhelix is indicated.
(B) A zoom-in view of the interaction interface between Pat1, Lsm2, and Lsm3 with conserved interacting residues highlighted and indicated.
(C) Evolutionary conservation of the Lsm2-3 binding region of Pat1C (helices 1A and 2A).
(D) Pull-down experiments of GST-tagged Pat1 residues (Mid + C-terminal domains) with untagged Lsm2-3, Lsm5-6-7, Lsm4, and Lsm1. Input samples (top) and
samples precipitated on glutathione-agarose beads (bottom) were analyzed on 4%–12% Bis-Tris NuPage gel with 2-(N-morpholino)ethanesulfonic acid running
buffer. The proteins corresponding to the bands are indicated on the right side of both panels. Asterisks indicate the precipitated bands.
(E) Pull-down experiments of GST-tagged Lsm2-3 (WT andmutants) withWT Pat1C and of GST-tagged Pat1CWT andmutants withWT Lsm2-3. The experiments
were carried out and are shown as described in (C).
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Conserved Interactions of Pat1 with Lsm2 and Lsm3
Pat1C binds Lsm1-7 at the Lsm2 and Lsm3 subunits (Figure 4A).
Helices 1A and 2A of Pat1C dock onto the C-terminal extension
of Lsm2 (helix a2) and onto the canonical helix of the Lsm3 core
(a1) (Figure 4B). A comparison of the yeast Lsm1B-7-Pat1C struc-
ture with that of human Pat1C and of yeast Lsm1A-7 in isolation
shows that the interacting regions do not undergo significant
conformational changes upon binding. Pat1, Lsm2, and Lsm3
are involved in an intricate set of electrostatic interactions.
Glu483Pat1 interacts with Arg87Lsm2 and Lys9Lsm3. Salt bridges
also occur between Arg538Pat1-Asp84Lsm2 and Lys534Pat1-
Asp13Lsm3. In addition, hydrophobic contacts engage
Leu479 Pat1, Tyr486Pat1, and Leu490Pat1 with Arg87Lsm2 and
Leu10Lsm3. All these residues are evolutionarily conserved (Fig-
ures 2B and 4C), suggesting that the metazoan orthologs share
a similar recognition mechanism. Indeed, substitution of some of
the equivalent residues in quadruple mutations of human Pat1
have been shown to impair Lsm1 binding in coimmunoprecipita-
tion assays (Braun et al., 2010).
The structural analysis predicts that the Lsm2-Lsm3 subcom-
plex is sufficient for Pat1C binding. We tested this hypothesis in
GST pull-down assays. A GST-Pat1 polypeptide encompassing
both the Mid and C-terminal domains was indeed able to precip-
itate Lsm2-3 and not Lsm1, Lsm4, or Lsm5-6-7 (Figure 4D). Next,
we engineered specific mutations. Consistent with the structure,
GST-Pat1C was unable to precipitate Lsm2-3 upon mutation of
Lsm2 Lys9Glu, Leu10Asp. Furthermore, mutation of Leu479Ala,
Glu483Lys in GST-Pat1C impaired the interaction with wild-type
(WT) Lsm2-3 (Figure 4E). The structural analysis also suggests a
possible mechanism for the recognition of the Mid domain of
Pat1. In both Lsm1-7 structures, part of the tag of Lsm2 is well
ordered and wedges between the a1 and a2 helices of Lsm2
(Figures 2A, 4A, and S1B). The Asn-Leu-Tyr-Phe-Gln sequence
of the tag interacts with evolutionarily conserved residues of
Lsm2 (Leu2, Lys8, and Thr9 on a1 and Leu82 and Ala85 on
a2). Interestingly, the Mid domain of Pat1 contains a similar
stretch of amino acids (Asp-Phe-Tyr-Phe-Gln, residues 304–
308 in S. cerevisiae Pat1) that are highly conserved and
embedded in a predicted unstructured region, both of which
are typical features of short linear motifs (Davey et al., 2012).
Thus, it is possible that the tag serendipitously mimics a short
linear motif in the Mid domain of Pat1.
Concluding Remarks
The Lsm1-7 complex contains an Sm ring with auxiliary struc-
tural features. The C-terminal extension that is characteristic of
Lsm1 partially occupies the internal channel of the Sm-like
ring. This extension approaches the RNA binding pockets of
Lsm1-7, providing a rationale for the observation that it en-
hances the RNA binding properties of the core (Chowdhury
et al., 2012). However, the basis for the specific recognition of
U tract RNAs presenting a short oligo-A tail is currently unclear
and an important question for future studies. The C-terminal
extension that is characteristic of Lsm2, and the canonical Sm
domains of Lsm2-Lsm3 create preformed protein-protein inter-
action sites. The C-terminal domain of Pat1 binds a composite
surface of Lsm2 and Lsm3 with a rather rigid recognition mech-
anism between folded domains. We speculate that the unstruc-
tured Mid domain of Pat1 (Braun et al., 2010) might flexibly dock
to an adjacent pocket of Lsm2 and enhance binding affinity.
Counterintuitively, the binding determinants for Pat1 are not
provided by Lsm1, the subunit of the cytoplasmic Lsm1-7 com-
plex that differs from the nuclear Lsm2-8 complex. This finding
has several implications. First, the localization of these proteins
to distinct subcellular compartments (Reijns et al., 2009) is likely
to provide a key contribution to binding specificity. Second, the
interaction surfaces of Lsm2-3 that we identified for the cyto-
plasmic Lsm1-7-Pat1 complex might also be involved in
protein-protein recognition in the nucleus in the context of the
nuclear Lsm2-8 complex. An interesting candidate for Lsm2-8
binding is the splicing factor Prp8, which appears to contain a
sequence similar to the Lsm2-Lsm3 binding region of Pat1
(data not shown). Given that, in human cells, Pat1 is a shuttling
protein with transient nuclear localization (Marnef et al., 2012),
it is also possible that Pat1 itself might interact with Lsm2-8,
rationalizing how Pat1 might exert its nuclear functions.
EXPERIMENTAL PROCEDURES
Protein Purification and Binding Assays
S. cerevisiae Lsm1-7 complexes were formed by mixing purified Lsm1, Lsm4,
Lsm2-3, and Lsm5-6-7 in a 2:2:1:1 ratio and reconstituted essentially as
described previously (Zaric et al., 2005). All Pat1 fragments were cloned as
either TEV-cleavable His6-ZZ-tagged or His6-GST-tagged proteins and puri-
fied with standard procedures. The octameric complex was reconstituted by
incubating the individually purified proteins in a 1:1.5 molar ratio of Lsm1-7
and Pat1 for 1 hr at 4!C. The complex was purified further by size-exclusion
chromatography (Superdex 200) in a buffer containing 20 mM Tris (pH 7.4),
150 mM NaCl, and 1 mM dithiothreitol. For in vitro pull-down experiments,
point mutations were introduced with QuikChange site-directed mutagenesis
according to the manufacturer’s instruction (Stratagene). Mutants were puri-
fied by similar protocol as for the WT Lsm1-7 and Lsm2-3. The pull-down
assays were carried out as described previously (Sharif et al., 2013). Protocols
are detailed in the Supplemental Information.
Crystal Structure Determination
Lsm1A-7 and LsmB1-7-Pat1C yielded crystals (conditions are detailed in the
Supplemental Information) that diffracted to 2.3 Å and 3.7 Å resolution, respec-
tively, with Swiss Light Source and European Synchrotron Radiation Facility
synchrotron radiation. Data were processed with XDS (Kabsch, 2010), and
the structures were solved by molecular replacement with Phaser (McCoy
et al., 2007). The atomic models were built with Coot (Emsley et al., 2010)
and refined with PHENIX (Adams et al., 2010). The data collection and refine-
ment statistics are summarized in Figure 1B.
ACCESSION NUMBERS
The coordinates and structure factors have been deposited in the Protein Data
Bank under accession numbers 4C92 for Lsm1A-7 and 4C8Q for Lsm1B-7-
Pat1C.
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Adams, P.D., Afonine, P.V., Bunkóczi, G., Chen, V.B., Davis, I.W.,
Echols, N., Headd, J.J., Hung, L.-W., Kapral, G.J., Grosse-Kunstleve,
R.W., et al. (2010). PHENIX: a comprehensive Python-based system for
macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr.
66, 213–221.
Andrade, M.A., Petosa, C., O’Donoghue, S.I., Müller, C.W., and Bork, P.
(2001). Comparison of ARM and HEAT protein repeats. J. Mol. Biol. 309,
1–18.
Bouveret, E., Rigaut, G., Shevchenko, A., Wilm, M., and Séraphin, B. (2000). A
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Supplemental data items 
 
 
 
Figure S1, Related to Figure 1 
Structural analysis of S. cerevisiae Lsm1-7 and Lsm1-7 - Pat1 
A) Limited proteolysis experiment identifies the minimal interacting regions of 
S. cerevisiae Lsm1-7 and Pat1. A complex of Lsm1-7 (with all proteins full-length, 
with the exception of a C-terminal truncation of Lsm4, as described in the main text) 
was purified by size-exclusion chromatography with Pat1 residues 220-796 (including 
the Mid and C-terminal domains), and the peak was incubated with elastase (Roche) 
in a 1:10 (wt/wt) enzyme:protein ratio for 30 min at 4°C. The products of the 
proteolysis were resolved on 4–12% Bis–Tris NuPage gel with MES running buffer.  
B) Electron densities (contoured at 1 sigma, with the final model superposed) for 
regions of the structures described in the text. Left panel: C-terminus of Lsm1 in the 
2.3 Å resolution Lsm1A-7 structure. Central panel: N-terminal tag of Lsm2 in the 2.3 
Å resolution Lsm1A-7 structure. Right panel: interacting region of Pat1, Lsm2 and 
Lsm3 in the 3.7 Å resolution Lsm1B-7 - Pat1 structure. 
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Figure S2, Related to Figure 2 
 
Distinct inter-subunit contacts 
 
The Lsm1-7 complex is viewed at the distal face, as in Figure 2A, left panel. Residues 
involved in specific intersubunit salt bridge interactions are highlighted. These 
interactions occur in addition to the largely hydrophobic contacts along the β-sheets 
of the Sm domains. 
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Figure S3, Related to Figure 3 
 
Accessibility of the RNA entry site and obstruction of the RNA exit site in Lsm1-
7 
The superposition of the structures in Figure 3 right and left panels shows that the C-
terminal extension of Lsm1 would clash against a ribonucleotide chain exiting the Sm 
ring with the same path observed in the U4 snRNP core (Leung et al., 2011). For 
clarity, Lsm1A-7 structure is shown here in blue and  U4 snRNP structure in gray. 
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Figure S4, Related to Figure 4 
 
The yeast Pat1C superhelix 
 
A) Helical-hairpin architecture of S. cerevisiae Pat1C. On the left, the structure is 
shown with each repeat in a different colour. On the right, the A helices of the repeats 
are in orange, the B helices in blue and the connecting regions in gray. 
B) The structure of S. cerevisiae Patc1C is shown in green superposed to the 
corresponding structure of the human orthologue (in gray) (from (Braun et al., 2010)). 
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Supplemental text section 
 
Supplemental Experiment Procedures 
 
Protein expression and purification 
 
S. cerevisiae Lsm1 constructs (full-length, residues 27-172 or residues 45-145) and 
Lsm4 (residues 1-114) were cloned as 3C-cleaveable His6-tagged proteins and 
expressed in BL21-Gold (DE3) pLysS cells (Stratagene). Lsm2-3 and Lsm5-6-7 
were expressed from polycistronic constructs as TEV cleavable His6-tagged proteins 
(kind gift of K. Nagai and Y. Kondo) in Rosetta-gami2 (DE3) pLysS cells 
(Novagen). All proteins were expressed in Terrific Broth (TB) medium at 18°C. 
Cells expressing Lsm1, Lsm4, Lsm2-3 and Lsm5-6-7 were mixed in a ratio of 
2:2:1:1, resuspended in lysis buffer (20 mM Tris pH 7.4, 500 mM NaCl, 25 mM 
Imidazole, 10 mM 2-Mercaptoethanol) and lysed by sonication. Proteins were 
purified using Nickel-based affinity chromatography. Eluted proteins were then 
treated in denaturing conditions at 4M Urea and 1M NaCl overnight at 4°C. On the 
next day proteins were incubated for 6 h at 37°C followed by gradual decrease of salt 
in the dialysis buffer at 4 °C for refolding and reconstitution of stoichiometric protein 
complex. Proteins were supplemented with TEV and 3C protease cocktail in final 
dialysis buffer (20 mM Tris pH 7.4, 150 mM NaCl, 10 mM 2-mercaptoethanol) for 
overnight at 4 °C. Proteins were further purified by ion exchange chromatography at 
pH 7.4 (MonoQ, GE Healthcare) followed by size-exclusion chromatography 
(Superdex 200, GE Healthcare). 
 
Pat1220-796 and Pat1450-796 proteins (with a TEV-cleavable His6-ZZ-tag or His6-GST-
tag) were expressed in BL21-Gold (DE3) pLysS cells (Stratagene) in TB medium at 
18°C. Cells were resuspended in lysis buffer supplemented with DNase and 
Phenylmethylsulfonyl Fluoride (PMSF), lysed by sonifaction and subjected to Nickel 
affinity purification. Tags were cleaved (where necessary) overnight in dialysis buffer 
with TEV protease followed by ion exchange chromatography (Heparin, GE 
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healthcare) at pH 7.4 and size exclusion chromatography (Superdex 200, GE 
Healthcare).  
 
 
Crystallization and structure determination 
 
Crystallization trials were carried out at 18°C and 10°C using the vapour diffusion 
method by mixing equal volumes of protein complex and crystallization buffer. 
Crystals of LsmA1-7 were obtained at 10 °C at 9.3 mg/ml. The best diffracting 
crystals of Lsm1A-7 complex were obtained in 100 mM MES pH 6.0, 40% MPD after 
5-10 days. Crystals were flash-frozen in liquid nitrogen directly from the 
crystallization drop, which diffracted to 2.3 Å resolution. Crystals of LsmB1-7-Pat1C 
were obtained at 10 °C at a concentration of 13 mg/ml in 100 mM HEPES pH 7.0, 
20% MPD, 10 mM hexamine cobalt (III) chloride in 3-4 weeks. The crystals were 
cryo protected by adding glycerol to crystal condition that diffracted to 3.7 Å 
resolution.  
The Lsm1A-7 structure was solved by molecular replacement with Phaser (McCoy et 
al., 2007) using the coordinates of Sm and Lsm proteins (Leung et al., 2011; Mund et 
al., 2011) as search models. The final model includes residues 43 - 172 of Lsm1, 1 -
 95 of Lsm2 (and additionally 10 residues of the N-terminal tag), 1 - 79 of Lsm3, 1 -
 84 of Lsm4, 4 - 87 of Lsm5, 10 - 86 of Lsm6 and 26 - 110 of Lsm7 (with the 
exception of a partially disordered loop between residues 72 - 81). The LsmB1-7-
Pat1C structure was solved by molecular replacement with LsmA1-7 and the human 
Pat1 orthologue (Braun et al., 2010). The low resolution LsmB1-7-Pat1C structure was 
refined in addition with reference model restraints with a high-resolution reference 
model (LsmA1-7 at 2.3 Å resolution). 
 
 
Pull-down assays 
 
Pull downs were performed by mixing 3-5 µg of GST-tagged (bait) protein with equal 
molar amounts of untagged (prey) protein. Binding buffer (20 mM Tris-Cl pH 7.4, 
150 mM NaCl, 10% glycerol, 1 mM DTT) was added to a final volume of 60 µl. The 
reaction mixtures were incubated on ice for 1 hour 17 µl of 50% (v/v) suspension of 
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GSH–Sepharose beads in 200 µl of binding buffer was added to each reaction mixture 
and incubated at 4 °C for 1 hour. Beads were washed three times with 500 µl binding 
buffer. Bound proteins were eluted with 20 mM reduced glutathione. Samples were 
resolved on SDS-PAGE and visualized by Coomassie blue stain. 
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4 Extended Discussion 
 
Discussion on each of two studies is presented in Sections 3.1 and 3.2. This section 
deals with the extended combined discussion and elaborates on the points made 
earlier. First two sections deals with Dhh1, Pat1 and Edc3 interactions related 
discussion. Later sections deal with discussion on the Lsm1-7-Pat1 complex and a 
combined discussion on general mechanisms related to both Sections. In the end, a 
broader perspective of the projects is discussed. 
 
4.1 Diversified functions of Dhh1 in mRNA decapping 
pathway 
 
Despite the highly conserved helicase core of DEAD box proteins some of their 
features are highly specific (Linder and Jankowsky, 2011). The Dhh1 structure 
reveals similar conserved helicase core, which consists of two RecA domains but with 
unusual inter-domain interactions (Cheng et al., 2005; Dutta et al., 2011). DEAD box 
proteins hydrolyze ATP in a closed conformation triggered by RNA and ATP binding 
that brings the two RecA domains together to provide composite surface for 
interaction with RNA (Linder and Jankowsky, 2011). Inter-domain interactions 
restrict ATPase activity of Dhh1 which shows weaker activity when compared to 
canonical DEAD box proteins (Dutta et al., 2011). The weaker the ATPase activity of 
Dhh1 is hypothesized to be required for stringent regulation of this cytoplasmic 
abundant protein (Dutta et al., 2011).  In Trypanosomes, Dhh1 copy number estimates 
to 400,000 copies per cell equals approximately six times molar excess of mRNAs 
(Kramer et al., 2010).  This number exceeds for mammalian cells where the 
DDX6/Me31B is available in higher number if repressed mRNAs are taken into 
consideration (Ernoult-Lange et al., 2012). Due to the abundance of Dhh1, multiple 
copies of it can bind to mRNA. This multiple binding may suppress interaction of 
additional factors with mRNA for storage purposes in P-bodies or eventually for their 
decay (Ernoult-Lange et al., 2012). 
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High cellular abundance with nanomolar binding affinity for RNA and restricted 
ATPase activity come in perspective for high regulation during translation repression 
and decapping. DEAD box proteins can thus play a RNA binding-only role or as 
RNA clamping proteins (Dutta et al., 2011; Linder and Jankowsky, 2011). Dhh1 
ATPase activity is not necessarily needed to bind RNA (Dutta et al., 2011). Domain 
movements of DEAD-box proteins can sometimes be achieved through binding a co-
factor which would release it from an inactive state resulting in rotation of the 
domains, ATP hydrolysis and ultimately release of RNA (Dutta et al., 2011; Ernoult-
Lange et al., 2012). Indeed recently, DDX6 interaction with CNOT1 protein (human 
ortholog of Not1 protein) in Ccr4-Not deadenylase complex, revealed how CNOT1 
binding modulates the active conformation of DDX6 that stimulates its ATPase 
activity (Mathys et al., 2014).  
  
4.2 Functions of small linear motifs in decapping protein-
protein interactions 
 
The decapping proteins interaction network contains many interactions that are 
mediated by small linear motifs present in intrinsically disordered regions of the 
proteins involved. Such regions are present in Pat1, Edc3, Scd6, Dcp1, Dcp2 and 
Xrn1 (Jonas and Izaurralde, 2013).  
The small linear motifs (SLiMs) belong to a class of disordered regions prevalent in 
many decapping proteins and in several other pathways including cell-signaling 
networks and gene transcription (Davey et al., 2012; Jonas and Izaurralde, 2013; 
Tantos et al., 2012). SLiMs size range from three up to ten residues and this small size 
confers a relatively low binding affinity when making direct contact with the 
interacting partner (Davey et al., 2012). Additionally, they are complimented with 
flanking disordered regions having an additive effect on their binding affinities 
(Davey et al., 2012; Tompa, 2012). Moreover, SLiMs have higher conservation than 
their neighboring regions and tend to form secondary structures upon binding to their 
partners (Davey et al., 2012; Tompa, 2012). 
SLiMs have been observed through biochemical/structural analysis combined with 
sequence analysis of Pat1 and Edc3 (Section 3.1). Pat1 and Edc3 contain the 
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FDF/DW motif implicated in binding to Dhh1/DDX6 (Section 3.1). Flanking 
FDF/DW motif, both proteins contain variable additional sites of interaction, which 
enhance their binding to Dhh1 (Dhh1 interaction surfaces, patch 2 and patch 3 
involved in interaction with Edc3 and Pat1, explained in Section 3.1). Moreover, 
Edc3 FDF motif peptide is unstructured in solution and adopts a helical structure upon 
binding to Dhh1 (Tritschler et al., 2009). Furthermore, FDF motifs of both the 
proteins are recognized by the same surface on Dhh1 (Section 3.1). These 
observations explain the evolutionarily plastic nature of SLiMs and their transient 
interactions in decapping pathway.  
 
4.3 Transient complex formation and mRNP remodeling 
during mRNA decay 
 
Over the years, functional and structural snapshots of protein factors involved in 
mRNA decay provided the clues concerning this intricate mechanism. The assembly 
of decapping complex on the repressed mRNAs is a complicated mechanism that 
includes interactions of catalytic factors and decapping activators in a network of 
protein-protein and protein-RNA interactions. The transient nature of complex 
formation increases the level of complexity in elaborating the working model of 
decay. This can be explained by multiple mRNP remodeling steps during the 
degradation process. 
The interactions may depend on sequence, binding preference as well as space and 
time (Moore, 2005). It can be argued that the interactions revise and rearrangements 
in mRNP take place during the decay. The proteins involved can have different 
function alone or when interacting with multiple partners. For example, Dhh1 directly 
interacts with mRNA and also functions in shuttling mRNAs to cytoplasmic foci 
(Dutta et al., 2011). Its interaction with Edc3 is necessary to repress the expression of 
mRNAs (Tritschler et al., 2009). Moreover, its interaction with Pat1 is required for 
the P-body formation and interaction with decapping enzyme Dcp2 at 5ʹ′-end of 
mRNAs (Ozgur and Stoecklin, 2013) 
Similarly, Dhh1 interaction with multiple partners on the same binding surface adds 
complexity to the protein interaction network. The transient Dhh1 complex formation 
4.4 Lessons learnt from the unusual C-terminal helix of Lsm1 
 
75 
triggered by proteins containing small linear motifs (SLiMs) may provide extra 
functionality for a limited time period until their interaction is not required. Structural 
and functional studies have shown that Dhh1 shares binding surface with RNA, Edc3, 
Scd6/Tral and Pat1, which give clues regarding its mutually exclusive binding to 
either of them (Haas et al., 2010; Ozgur et al., 2010). Switching partners also explains 
that Pat1 and Edc3 proteins in yeast have the capability to detach Dhh1 from 
interaction with RNA or vice versa. Alternatively, Dhh1, due to its abundance in the 
cytoplasm as compared to Pat1 and Lsm1-7, could exist in multiple interactions, in 
mRNA bound form, in complex with Edc3 and with Pat1 simultaneously (Section 
3.1).  
Certain mRNA features including AU-rich elements (AREs) and the status of the 3ʹ′-
poly(A) or 5ʹ′ cap structure could guide these positional preferences (Mitchell et al., 
2013). Moreover, presence of certain mRNA binding proteins at specific sequences 
could also guide positional specific recruitment. This site-specific recruitment has 
functional values as well and may regulate the protein functions during translational 
repression, deadenylation and decapping events (Mitchell et al., 2013).  
 
4.4 Lessons learnt from the unusual C-terminal helix of Lsm1 
 
The Lsm1-7 complex shows structural integrity in preserving hetero-heptameric 
assembly and Sm-folds in each subunit (Section 3.2). However, the most surprising 
finding by the structural analysis is the helical extension of Lsm1 C-terminus. It 
protrudes inside the channel made by heptameric complex. Structural comparison 
with U4 snRNP complex reveals that the helical C-terminal Lsm1 may obstruct the 
incoming 3ʹ′-end of RNA through the central pore made by seven subunits. Indeed, 
earlier biochemical evidence from in vivo truncation of Lsm1 and in vitro purified 
Pat1-Lsm1-7 complex lacking Lsm1 C-terminal shows severe mRNA decay 
impairment and weaker mRNA binding affinities respectively (Chowdhury et al., 
2012).  
Based on structural analysis two possible scenarios can be hypothesized for possible 
functions of the helical extension of Lsm1. First, it could block the channel and thus 
blocking the exit of 3ʹ′-end of mRNA from distal face of the complex. In this way, 
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helix must provide the specificity to bind 3ʹ′-end of mRNA thus providing rationality 
to the earlier observations. Second, unknown interaction partner(s) of Pat1-Lsm1-7 
complex may induce conformational change in the Lsm1 C-terminal helix. This 
change in conformation may allow release of helix from blocking the channel that 
would allow 3ʹ′-end of mRNAs to thread through the channel.  
 
4.5 Pat1 distinct domains provide the structural basis for 
interaction with Lsm1-7 and other decapping activators 
 
Biochemical analysis of purified proteins in in vitro pull-downs supplemented with 
structural information revealed that Pat1 C-terminal interacts with composite surface 
provided by Lsm2 and Lsm3 in Pat1-Lsm1-7 complex structure (Section 3.2). These 
interactions are surprisingly different from previously proposed model of Pat1 
interaction with Lsm1-7 in which cytoplasmic specific subunit Lsm1 was suggested to 
provide specificity to bind Pat1. Interestingly, a conserved motif in Pat1 middle 
domain is speculated to bind the conserved surface on Lsm2. 
The unique property of Pat1-Lsm1-7 complex is the ability to distinguish and bind to 
oligoadenylated RNAs rather than poly or unadenylated RNAs (Chowdhury and 
Tharun, 2008). Specificity is predicted to be provided by the Lsm1-7 complex, which 
prefers binding to U-stretch near 3ʹ′ end of mRNAs (Chowdhury and Tharun, 2008). 
However, Pat1 also binds RNA preferably poly(U) RNA. Its C-terminal domain has a 
basic patch involved in RNA binding (Braun et al., 2010). The relative contribution of 
RNA binding ability of the complex can be envisioned as Pat1 provides extra surface 
for binding RNA in addition to binding specificity provided by Lsm1-7. Pat1 middle 
and C-terminal domains are also involved in interaction with Xrn1, Dcp1, Dcp2 and 
RNA and these are mediated by a conserved surface on Pat1 C-terminus, which 
provide the basis of simultaneous binding of these factors (Jonas and Izaurralde, 
2013).  
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4.6 Cross-talk between mRNA decapping and deadenylation 
 
Deadenylation dependent mRNA degradation pathways are highly conserved in all 
eukaryotes (Garneau et al., 2007).  The association between deadenylation and 
decapping remains poorly understood. Only few clues can be gathered from the 
literature but mechanistic details of the coupling of two important events in the 
mRNA degradation still remain to be investigated.  
Pat1 middle and P-rich domain has been shown to interact with the components of 
Ccr4-Not complex in Drosophila and human proteins (Haas et al., 2010; Ozgur et al., 
2010). The fact that both the unstructured and low complexity domains are mediated 
in these interactions highlights the difficulty of in vitro purifications and 
characterization of these interactions (Haas et al., 2010; Jonas and Izaurralde, 2013; 
Ozgur et al., 2010). Furthermore, the Lsm1-7 complex preference for interaction with 
the deadenylated mRNAs (Chowdhury et al., 2007) hints on to that Pat1 may interact 
first with the deadenylase complex and then helps recruiting of the Lsm1-7 complex 
on the mRNAs. Similarly, interaction of Dhh1 with the components of Ccr4-Not 
complex has been observed (Coller et al., 2001). Indeed, recent structure of human 
DDX6 bound with MIF4G domain of CNOT1 revealed for the first time molecular 
basis of decapping activator protein interaction with the deadenylase complex 
(Mathys et al., 2014).  
With this information in hand, Dhh1 could be regarded as a bridging protein between 
deadenylation and decapping because of its interaction with Pat1 and Not1 proteins. 
What role does Pat1 play when interacting with Ccr4-Not complex? Whether the 
interactions are direct or via Dhh1? What are the implications in these interactions 
remain yet to be identified. 
 
4.7 Pat1 provides the link between 5' and 3'-ends of mRNA 
 
Pat1 is a key decapping activator protein and its deletion from yeast strain shows 
strong defects in mRNA decapping, similar to deletion of decapping enzyme Dcp1 
and Dcp2 (Nissan et al., 2010; Tharun et al., 2000). The importance of Pat1 in 
decapping and other associated decay processes can be explained by its plethora of 
4 Extended Discussion      78 
interactions with decapping proteins by providing a scaffold for interactions (Nissan 
et al., 2010). Dhh1, Pat1 and Lsm1-7 proteins show positional specificity relative to 
mRNA rather than sequence specificity. Pat1 and Lsm1-7 show binding preference 
towards the 3ʹ′-end and can also be purified as a separate complex together with Xrn1 
(Bouveret et al., 2000). Whereas, Dhh1 has higher propensity to bind near the 5ʹ′-end 
of mRNAs and can be co-purified with decapping enzymes Dcp1-Dcp2 and Edc3 
(Mitchell et al., 2013).  
In sections, 3.1 and 3.2, Pat1 interactions with Dhh1 and Lsm1-7 complex have been 
shown biochemically and through structural analysis. In this way for the first time, 
Pat1 has been shown to interact with two distinct protein complexes known to interact 
at 3ʹ′ and 5ʹ′-end of mRNA respectively (Figure 4.1). In addition, it can be concluded 
that mRNA circular architecture is maintained until the 5ʹ′-exoribonucleotic activity of 
Xrn1 is taken over for mRNA degradation (Figure 4.1). 
 
 
 
Figure 4.1: Circular mRNA model with decapping complex  
 
Summary of the Sections 3.1 and 3.2. Dhh1 is shown in all the interactions it is 
involved in, i.e. bound to Pat1-NTD, Edc3-FDF and with RNA simultaneously 
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(Section 3.1). Pat1-Mid domain is represented as intrinsically disordered region with 
dashed line and its putative interaction with Lsm2. Pat1-CTD representation bound 
with Lsm1-7 complex (Section 3.2). Also interactions of Pat1 and Dhh1 with Dcp2 are 
depicted as putative interactions described in (Nissan et al., 2010). Structural 
information of Xrn1 interaction with Pat1 and Lsm1-7 complex is still elusive. 
 
 
Additional to these interactions, Pat1 as well as Dhh1 engage in interactions with 
Dcp2 and enhances its decapping activity (Nissan et al., 2010). It would be interesting 
to understand how does these interactions remodel mRNP overall when implicated in 
these multiple interactions. Whether the interactions can occur simultaneously or are 
mutually exclusive.   
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5 Outlook 
 
 
Recent advancements in structural understanding of decapping activators have opened 
a vast range of open questions regarding their role in mRNA turnover. Dhh1 involved 
in mutually exclusive interactions is a compelling target for further functional studies. 
It would be interesting to understand how mutually exclusive interactions effect the 
decapping process. Further dissection of Dhh1 direct interaction with other 
modulating factors, which are involved in imparting its functions in translation 
repression and deadenylation, is worthwhile.  
Pat1 structure solved with Lsm1-7 complex open a wide range of questions for future 
studies. With further structure elucidation a number of possible questions can be 
answered. Structural snapshots of Lsm1-7-Pat1 and Lsm1-7 complex bound to RNA 
can give details regarding how this complex recognizes 3ʹ′ oligoadenylated mRNAs. 
In terms of larger assembly of proteins involved in mRNA decapping and decay, it 
would be exciting to get atomic or high resolution electron microscopy structures of 
complex including Pat1, Lsm1-7, Dhh1, Dcp1-Dcp2, Xrn1 and other interacting 
factors involved in making stable decapping complex. Moreover, snapshots of 
transient complexes involved in this larger assembly and how it effects the overall 
decapping and at what step.  
From functional point of view, it is intriguing how actively translating mRNAs are 
brought to a repressed state and in which direct interactions Pat1 and Dhh1 are 
involved in during translation repression and deadenylation? The sequence of how 
mRNA decapping activators are recruited to the oligoadenylated mRNAs? How 
mRNA decapping machinery is assembled on the repressed mRNA? These questions 
are the foremost questions in the field. 
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